ArticlePDF Available

Abstract and Figures

Position Statement: The International Society of Sports Nutrition (ISSN) bases the following position stand on a critical analysis of the literature on the safety and efficacy of the use of energy drinks (ED) or energy shots (ES). The ISSN has concluded the following. 1. Although ED and ES contain a number of nutrients that are purported to affect mental and/or physical performance, the primary ergogenic nutrients in most ED and ES appear to be carbohydrate and/or caffeine. 2. The ergogenic value of caffeine on mental and physical performance has been well-established but the potential additive benefits of other nutrients contained in ED and ES remains to be determined. 3. Consuming ED 10-60 minutes before exercise can improve mental focus, alertness, anaerobic performance, and/or endurance performance. 4. Many ED and ES contain numerous ingredients; these products in particular merit further study to demonstrate their safety and potential effects on physical and mental performance. 5. There is some limited evidence that consumption of low-calorie ED during training and/or weight loss trials may provide ergogenic benefit and/or promote a small amount of additional fat loss. However, ingestion of higher calorie ED may promote weight gain if the energy intake from consumption of ED is not carefully considered as part of the total daily energy intake. 6. Athletes should consider the impact of ingesting high glycemic load carbohydrates on metabolic health, blood glucose and insulin levels, as well as the effects of caffeine and other stimulants on motor skill performance. 7. Children and adolescents should only consider use of ED or ES with parental approval after consideration of the amount of carbohydrate, caffeine, and other nutrients contained in the ED or ES and a thorough understanding of the potential side effects. 8. Indiscriminant use of ED or ES, especially if more than one serving per day is consumed, may lead to adverse events and harmful side effects. 9. Diabetics and individuals with pre-existing cardiovascular, metabolic, hepatorenal, and neurologic disease who are taking medications that may be affected by high glycemic load foods, caffeine, and/or other stimulants should avoid use of ED and/or ES unless approved by their physician.
Content may be subject to copyright.
R E V I E W Open Access
International Society of Sports Nutrition position
stand: energy drinks
Bill Campbell
1
, Colin Wilborn
2
, Paul La Bounty
3
, Lem Taylor
2
, Mike T Nelson
4
, Mike Greenwood
5
,
Tim N Ziegenfuss
6
, Hector L Lopez
6
, Jay R Hoffman
7
, Jeffrey R Stout
7
, Stephen Schmitz
8
, Rick Collins
9
,
Doug S Kalman
10
, Jose Antonio
11
and Richard B Kreider
5*
Abstract
Position Statement: The International Society of Sports Nutrition (ISSN) bases the following position stand on a
critical analysis of the literature on the safety and efficacy of the use of energy drinks (ED) or energy shots (ES).
The ISSN has concluded the following. 1. Although ED and ES contain a number of nutrients that are purported to
affect mental and/or physical performance, the primary ergogenic nutrients in most ED and ES appear to be
carbohydrate and/or caffeine. 2. The ergogenic value of caffeine on mental and physical performance has been
well-established but the potential additive benefits of other nutrients contained in ED and ES remains to be
determined. 3. Consuming ED 10-60 minutes before exercise can improve mental focus, alertness, anaerobic
performance, and/or endurance performance. 4. Many ED and ES contain numerous ingredients; these products in
particular merit further study to demonstrate their safety and potential effects on physical and mental performance.
5. There is some limited evidence that consumption of low-calorie ED during training and/or weight loss trials may
provide ergogenic benefit and/or promote a small amount of additional fat loss. However, ingestion of higher
calorie ED may promote weight gain if the energy intake from consumption of ED is not carefully considered as
part of the total daily energy intake. 6. Athletes should consider the impact of ingesting high glycemic load
carbohydrates on metabolic health, blood glucose and insulin levels, as well as the effects of caffeine and other
stimulants on motor skill performance. 7. Children and adolescents should only consider use of ED or ES with
parental approval after consideration of the amount of carbohydrate, caffeine, and other nutrients contained in the
ED or ES and a thorough understanding of the potential side effects. 8. Indiscriminant use of ED or ES, especially if
more than one serving per day is consumed, may lead to adverse events and harmful side effects. 9. Diabetics and
individuals with pre-existing cardiovascular, metabolic, hepatorenal, and neurologic disease who are taking
medications that may be affected by high glycemic load foods, caffeine, and/or other stimulants should avoid use
of ED and/or ES unless approved by their physician.
Introduction
According to published research, energy drinks (ED) are
the most popular dietary supplement besides multivita-
mins in the American adolescent and young adult popu-
lation [1-3]. ED are also reported to be the most popular
supplement among British athletes [4]. More recently,
energy shots (ES) have also been purported to possess
ergogenic value on mental focus and/or performance
[5]. It is important to make a distinction between ED,
ES, and sports drinks. Sports drinks are a unique cate-
gory within the beverage industry and are marketed to
consumers with the primary function of promoting hy-
dration, replacing electrolytes and sustaining endurance
performance capacity. They typically provide a small
amount of carbohydrate (e.g., 6-8 grams/100 ml) and
electrolytes (sodium, potassium, calcium, magnesium).
ED, on the other hand, typically contain higher amounts
of carbohydrate along with nutrients purported to im-
prove perceptions of attention and/or mental alertness.
Low calorie ED are also marketed to increase mental
alertness, energy metabolism, and performance. Energy
shots are typically 2-4 oz. servings of concentrated fluid
* Correspondence: rkreider@hlkn.tamu.edu
Equal contributors
5
Exercise & Sport Nutrition Lab, Department of Health & Kinesiology, Texas
A&M University, College Station, Texas, TX 77843-4243, USA
Full list of author information is available at the end of the article
© 2013 Campbell et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1
http://www.jissn.com/content/10/1/1
containing various purported ergogens. Since ED and ES
contain carbohydrate, caffeine, and/or nutrients that may
affect mental focus and concentration, they have the
potential to affect exercise capacity and perceptions of
energy and/or fatigue. The purpose of this position stand
is to critically evaluate the scientific literature and make
recommendations in regards to the role that ED and/or
ES may have on exercise performance and energy ex-
penditure/metabolism. Additionally, we will discuss safety
considerations in regards to the use of ED and/or ES.
Methods
This analysis represents a systematic review of the literature
on the effects of energy drinkson exercise and cognitive
performance as well as primary ingredients contained in
popular energy drinks. A comprehensive literature search
was performed by searching the Medline database of the
US National Library of Medicine of the National Institutes
of Health. The search strategy involved entering energy
drinksand commercial names of energy drinks and/or caf-
feinated beverages as well as a search of primary nutrients
contained in popular energy drinks (e.g., caffeine, carbohy-
drate, taurine, glucoronolactone, Guarana, Yerba Mate,
etc.). It is important to note, from a United States regula-
tory perspective, several of these ED are marketed as diet-
ary supplements and not beverages, and the label on the
product will indicate which category of Food and Drug
Administration (FDA) authority the product falls under.
Each category has its own set of governing laws and regula-
tions. For example, depending on the category, the labels
will include Supplement Facts (dietary supplements) or
Nutrition Facts (beverages). A paper summarizing the
literature related to ED was presented at the 2011
International Society of Sports Nutrition Annual meeting.
Thereafter, a position stand writing team was organized to
develop this paper. Drafts of this position stand were then
reviewed by all authors as well as the Research Committee
of the International Society of Sports Nutrition (ISSN).
The final version of this paper was then adopted as the
official position of the ISSN.
Ergogenic/performance considerations
The ingestion of nutrients prior to, during, and/or fol-
lowing exercise can affect exercise performance and/or
training adaptations [6]. ED typically contain water, car-
bohydrates (e.g., glucose, maltodextrin), vitamins, minerals,
and proprietary blendsof various nutrients purported to
increase energy, alertness, metabolism, and/or perform-
ance (e.g., caffeine, taurine, amino acids, glucoronolactone,
Guarana, Ginkgo biloba, Carnitine, Panax ginseng, Green
Tea, Yerba Mate, etc.). Therefore, ingestion of ED or ES
prior to, during, and/or following exercise could have
some ergogenic value. Tables 1 and 2 present a list of
ingredients found in several ED/ES marketed in the
United States. The next section provides an overview of
the potential ergogenic value of some of the most com-
monly found nutrients in ED/ES.
Caffeine
Caffeine is the most common ingredient utilized in
energy drinks. Caffeine is extracted from the raw fruit of
over sixty species of coffee plants (coffea Arabica), all
part of the methylxanthine family. Caffeine is also
extracted from tea, kola nuts, and cocoa. After ingestion,
caffeine is quickly absorbed and increases in plasma con-
centrations are generally observed between 30 60 min-
utes following ingestion [7]. The difference in absorption
time is dependent on the physicochemical formulation
properties of the product dose [8]. Caffeine is a strong
cardiovascular stimulant that increases epinephrine out-
put to a greater extent when ingested via its anhydrous
formulation when compared to an equal amount of
brewed or instant caffeinated coffee [9,10]. In addition,
caffeines half-life ranges from approximately 2 to 10
hours with 0.5% - 3.5% of its content excreted un-
changed in urine and select amounts eliminated via per-
spiration [11]. A recent position stand from the Journal
of the International Society of Sports Nutrition [7] sum-
marized the effects of caffeine on exercise performance
as follows:
1. Caffeine is effective for enhancing sport performance
in trained athletes when consumed in low-to-moderate
dosages (~3-6 mg·kgBM
-1
) and overall does not result
in further enhancement in performance when
consumed in higher dosages (9 mg·kgBM
-1
).
2. Caffeine exerts a greater ergogenic effect when
consumed in an anhydrous state as compared to coffee.
3. It has been shown that caffeine can enhance
vigilance during bouts of extended exhaustive
exercise, as well as periods of sustained sleep
deprivation.
4. Caffeine is ergogenic for sustained maximal
endurance exercise, and has been shown to be highly
effective for time-trial performance.
5. Caffeine supplementation is beneficial for
high-intensity exercise, including team sports such as
soccer and rugby, both of which are categorized by
intermittent activity within a period of prolonged
duration.
6. The literature is equivocal when considering the
effects of caffeine supplementation on strength-power
performance, and additional research in this area is
warranted.
7. The scientific literature does not support
caffeine-induced diuresis during exercise, or any
harmful change in fluid balance that would
negatively affect performance.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 2 of 16
http://www.jissn.com/content/10/1/1
Table 1 List of ingredients described on nutrient panels found in some energy drinks
Ingredient A B C D E
Calories 100 110 140 120 140
Carbohydrate 27 28 31 32 30
Calories from
Fat
--- -
Vitamin C - 100 mg - 100 mg 6.7mg
Thiamin - 0.1 mg - - 0.2 mg
Riboflavin B2 1.7 mg 1.5 mg 3.4 mg 20% 0.2 mg
Niacin B3 20 mg 21.7 mg 20 mg 10% 2.2 mg
Vitamin B6 40 mg 2.1 mg 2 mg 10% 1.5 mg
Vitamin B12 6 mcg 4.5 mcg 6 mcg 10% 4.7 mcg
Pantothenic
Acid
- 36 mg - 10% 1.1 mg
Sodium 180 mg 200 mg 40 mg 75 mg 190 mg
Potassium - 10 mg 10 mg - 65 mg
Phosphorus - - - 40 mg 90 mg
Taurine 1,000 mg 600 mg 1000 mg - -
Panax
Ginseng
200 mg - 25 - -
Proprietary
Blend
2,500 mg L-Carnitine, Glucose,
Caffeine, Guarana, Inositol,
Glucuronolactone, Maltodextrin
Caffeine
(77 mg)
325 mg Ginko Biloba (150 mg),
Caffeine (80 mg), Guarana (25 mg),
Inositol (25 mg), L-Carnitine (25 mg),
Milk Thistle (20 mg)
Guarana, maltodextrin,
caffeine, taurine,
panax ginseng,
calcium
Citrulline Malate,
L-Glutamine,
L-Arginine, Quercetin,
L-Leucine, L-Valine,
Table 2 List of ingredients described on nutrient panels found in some energy shots
Ingredient A B C D E
Calories 4 4 20 9 0
Carbohydrate - - 4 g 1 g 0
Calories from
Fat
----
Vitamin C - 100 mg - - 126%
Niacin 30 mg 33 mg 33 mg -
Vitamin B6 40 mg 40 mg 40 mg -
Folic Acid 400 mcg 400 mcg 400 mcg -
Vitamin B12 500 mcg 500 mcg 500 mcg -
Sodium 18 mg 0 mg 0 mg - 10
Potassium - 10 mg 10 mg - 26
Proprietary 1,870 mg 2,300 mg 2,200 mg 910 mg 527 mg
Blend Taurine,
Glucuronolactone,
Malic Acid,
N-Acetyl
L-Tyrosine,
L-Phenylalanine,
Caffeine, Citicoline
Glucouronolactone (425 mg),
N-Acetyl L-Tyrosine (400 mg),
L-Phenylalanine (375 mg),
Taurine (350 mg),
Malic Acid 300 mg),
Caffeine (200 mg),
Green Tea Extract (150 mg),
Ginseng Extract (150 mg)
Glucouronolactone (420 mg),
L-Phenylalanine (380 mg),
D-Ribose (350 mg),
N-Acetyl L-Tyrosine (325 mg),
Malic Acid (300 mg),
Caffeine (175 mg),
Green Tea Extract (150 mg),
Ginseng Extract (100 mg)
Caffeine Citrate,
Caffeine Anhydrous,
Evoburn,
Octapomine,
Gugulsterone E & Z,
Yerbe Mate,
Green Tea,
Synephrine, cAMP,
Vinpocetine,
Yohimbe HCL
Beta-Alanine, Vitamin C,
Caffeine Anhydrous
(158 mg), Evoburn,
N-Acetyl-L-Tyrosine,
Hordinine,
5-Hydroxy-L-Trypotophan
(5-HTP), Potassium,
N-methyl Tyramine,
Sulbutlamine,
Vinpocetine,
Yohimbine HCI,
St. Johns Wort Extract
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 3 of 16
http://www.jissn.com/content/10/1/1
As demonstrated below, several studies have reported
significant improvements in both aerobic and resistance
exercise with a relative dosage of approximately 2
mg·kgBM
-1
of caffeine. This is less than the amount
recommended (3-6 mg·kgBM
-1
) to enhance perform-
ance [7], and may contribute to the hypothesis that the
synergistic effects of the various ingredients contained
in ED/ES are responsible for the reported improve-
ments in exercise performance.
Carbohydrate
Another common ingredient in most ED is some type of
carbohydrate source (e.g., glucose, sucrose, maltodextrin,
etc.). Energy drinks also typically contain glucuronolac-
tone, an ingredient which is involved in ascorbic acid
synthesis and is metabolized into xylulose [12]. Evidence
from numerous studies indicates that carbohydrate fee-
ding during exercise of about 45 minutes or longer can
improve endurance capacity and performance [13,14].
Mechanisms by which carbohydrate feeding prior to
and during exercise improves endurance performance
include maintaining blood glucose levels, maintaining
high levels of carbohydrate oxidation, and the sparing
of liver and possibly skeletal muscle glycogen [15]. Peak
rates of carbohydrate oxidation are commonly around
1 g of carbohydrate per minute or 60 g·hr
-1
.Glucose,
sucrose, maltodextrins and amylopectin are oxidized at
high rates, while fructose, galactose and amylose are
oxidized at lower rates (approximately 25-50% lower)
[16]. Consequently, sports drinks typically contain a
mixture of various types of carbohydrates designed to
optimize exogenous carbohydrate oxidation [17].
EDs contain approximately 25-30 grams of carbohy-
drate per 240 mL (8 fluid ounces) serving. This amount
nearly meets the lower value of 30 grams/hour recom-
mended during endurance exercise, but falls short of the
upper range of 60 g·hr
-1
. In order to meet this upper level
of 60 grams of carbohydrate per hour during endurance
exercise, approximately 530 mL (18 fluid ounces) of a
typical ED per hour would need to be consumed. While
the total carbohydrate content of typical ED is quite high,
a shortcoming exists in regards to the concentration of
commercially available energy drinks. The American
College of Sports Medicine [18] and the ISSN [6,17]
recommend ingesting carbohydrate in a 6-8% solution
(6-8 grams per 100 ml of fluid) during endurance exercise.
A typical ED provides carbohydrates at a greater concen-
tration, typically around an 11-12% solution. Ingesting
higher percentages (>10%) of carbohydrate in fluids has
been reported to delay gastric emptying and increase
gastrointestinal distress [19,20]. Consequently, athletes
who want to use ED as sports drinks may need to dilute
the beverage and/or alternate consumption of ED and
water during exercise.
Other nutrients
Tables 3, 4, and 5 present a list of additional nutrients
commonly found in ED or ES. Most ED and ES also
contain a small amount of vitamins (e.g., thiamin, ribo-
flavin, niacin, Vitamin B6, Vitamin B12, pantothenic
acid, Vitamin C) and electrolytes (e.g., sodium, potas-
sium, phosphorus, etc.). While the addition of these
nutrients may add to the nutrient density of these
products, there is little evidence that ingestion of these
vitamins and minerals in the amounts found in ED and ES
would provide any ergogenic benefit during exercise per-
formance in well-nourished individuals [17,18]. Additio-
nally, ED and ES typically contain nutrients purported to
promote cognition and mental focus (e.g., Taurine, Ginkgo
biloba, L-Tyrosine, Citocoline, 5-Hydroxy-L-Tryptophan
[5-HTP], St. Johns Wort, etc.), stimulants (e.g., caffeine,
Guarana, Green Tea, Synephrine, Yerba mate, Yohimbine,
Tyramine, Vinpocetine, etc.), and/or various purported
ergogenic nutrients (e.g., Panax Ginseng, L-Carnitine,
D-Ribose, β-Alanine, Inositol, Citrulline, Quercetin, etc.).
While there are data to support the potential ergogenic
value of some of these nutrients on cognitive function
and/or exercise capacity [17,18]; the amounts found in ED
and ES are generally much lower than the typical concen-
trations associated with an ergogenic effect. Consequently,
it is unclear whether adding these nutrients to ED and/or
ES provides a synergistic or additive effect to the carbohy-
drate and caffeine found in these products. In addition,
adding these nutrients to the caffeine found in ED and/or
ES may change the adverse effect profile of these finished
products, and warrant further study.
Exercise performance
Several studies have investigated the effects of ED con-
sumption prior to exercise. The types of exercise that
were evaluated include resistance exercise [167,168], an-
aerobic exercise [169], and aerobic/endurance exercise
[62,170-172].
Ingestion prior to anaerobic exercise
Many of the studies investigating the effects of ED in-
gestion on anaerobic performance measures have been
conducted within the past several years. In a crossover
study (separated by seven days), Forbes and colleagues
[168] gave 15 physically active college-aged students a
commercially available energy drink standardized with
2 mg·kgBM
-1
of caffeine or an isoenergetic, isovolu-
metric, non-caffeinated placebo 60-minutes prior to
exercise. The exercise consisted of three sets of 70% one
repetition maximum (1RM) bench press conducted to fai-
lure on each set with one minute of rest between each set.
Following the resistance exercise bout, three x 30-second
Wingate Anaerobic Capacity tests were also conducted
with two minutes of rest between each test. The ED
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 4 of 16
http://www.jissn.com/content/10/1/1
significantly increased total bench press repetitions over
three sets (approximately 6% more repetitions completed)
but had no effect on Wingate peak or average power.
In a similarly designed study, a commercially available
energy drink (providing an average of 2.1 mg of caffeine
per kg of body mass) given to physically active male and
female participants 45 minutes prior to exercise resulted
in a significant increase in leg press total lifting volume
(12% increase as compared to a carbohydrate placebo)
but had no effect on bench press total lifting volume
[167] or multiple 20-second Wingate-type cycle sprints
[173]. Hoffman and colleagues [169] gave male strength/
power athletes an ED containing an average of 1.8
mg·kgBM
-1
of caffeine or a placebo beverage that was
similar in taste and appearance but contained only inert
substances. Following the ingestion of the ED, three
separate 20-second Wingate tests separated by about 15
minutes were performed. Results revealed that there
were no significant differences between trials in any an-
aerobic power measure. In a recent publication, 12
healthy male and female non-resistance trained partici-
pants ingested a commercially available ED standardized
at either 1 or 3 mg·kgBM
-1
of caffeine or a placebo beve-
rage (containing no caffeine) in a randomized, repeated
measures design [65]. Sixty minutes following beverage
ingestion, each participant completed 10-to-100% 1RM
Table 3 Potential ergogenic nutrients contained in energy drinks that may affect cognition and/or mental performance
Ingredient Potential ergogenic value Scientific support
Taurine Improved mental focus, concentration, serve as antioxidant,
glucose homeostasis [21-24]
Some supportive evidence with ED and fed animals
[25-35]
Gingko Biloba Improve memory and mental concentration Some supportive evidence on memory (e.g., 120 mg/d)
[36-39]. No known effects at dosages found in ED or ES.
L-Tyrosine Prevents depletion of catecholamines, may ameliorate declines in
cognition with acute stress [40-47]
Some supportive evidence on cognition (e.g., 2 g/d,
150 mg acute ingestion with cold exposure)
[41,43,46,48,49]. No effects on performance capacity
[42,50]. No known effects at dosages found in ED or ES.
Citicoline Intermediate in the generation of phosphatidylcholine from choline.
Increase dopamine receptor densities and delay memory
impairment [51,52].
Some supportive evidence with large doses
(8.5 g prior to and during exercise) and in fed animals
[52]. No known effects at dosages found in ED or ES.
5-Hydroxy-L-
Trypotophan
(5-HTP)
Precursor to serotonin [53,54]. Purported antidepressant,
appetite suppressant, & sleep aid [53,55-58].
Some evidence in treatment of depression [53,55-58]
and 5-HT fed animals on muscle performance [54,59,60].
Role on exercise performance at dosages found in ED
and ES is unknown.
St. Johns Wort Anti-depressant [56-58]. Some supportive evidence [56-58]. No known effects at
dosages found in ED or ES.
Table 4 Potential stimulants contained in energy drinks that may affect performance capacity
Ingredient Potential ergogenic value Scientific support
Caffeine Stimulant. Increases metabolism and lipolysis [2,8,9,61]. Increases alertness, mood, cognitive function [2,8,9,61].
Increases fat oxidation, spares glycogen utilization,
improves exercise [7,9-11,62-65].
Guarana Natural source of caffeine. Similar properties to caffeine. Similar to caffeine effects.
Green Tea
Extract
Contains high amounts of caffeine and catechin polyphenols
(e.g., epigallocatechin gallate or EGCG). Serves as antioxidant.
Similar effects as caffeine [66,67]
Some supportive evidence of increased metabolism
[68-76]. Specific role at dosages found in ED is unknown.
Synephrine Alternative to ephedrine. Naturally derived from Citrus aurantium. Stimulant
with less cardiovascular effects than ephedrine.
Purported to increase metabolism and promote weight loss.
Evidence of a mild stimulant effect on metabolism and
weight loss [77-82]. No known effects at dosages found
in ED.
Yerba mate Contains three xanthines (caffeine, theobromine, and theophylline). Similar
properties to caffeine
Similar to caffeine effects. Some supportive evidence
[83-85] No known effects at dosages found in ED
and ES.
Yohimbine Alkaloid with stimulant and aphrodisiac properties [86-90]. Similar to caffeine effects. Effects at dosages found in ED
are unknown.
Tyramine Naturally-occurring monoamine derived from tyrosine. Acts as a
catecholamine (dopamine, NE, Epi) releasing agent. Degraded to octopine.
Increases blood pressure and can serve as neurotransmitter [91-93].
Mild cardiovascular stimulant. Effects at dosages found
in ED / ES are unknown.
Vinpocetine Alkaloid of vincamine extracted from periwinkle plant (Vinca) minor.
Vasodilatory and memory enhancing properties [94,95].
No known effects at dosages found in ED or ES.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 5 of 16
http://www.jissn.com/content/10/1/1
power-load tests for the bench press and half-squat. Inges-
tion of the ED with 1 mg·kgBM
-1
of caffeine was not
enough to raise the power output during the power-load
tests. However, the ingestion of an ED with 3 mg·kgBM
-1
of
caffeine increased maximal power output by 7% in both
the half-squat and bench-press as compared to the inges-
tion of a placebo [65]. A recent study by Gonzalez and
colleagues [174] indicated that an energy matrix consis-
ting of caffeine, taurine and glucoronolactone consumed
10-min prior to a workout resulted in an 11.9% improve-
ment (p < 0.05) in the number of repetitions performed
during 4 sets of the squat or bench press exercise using
80% of the subjects 1-RM. In addition, the average power
output for the workout was significantly higher for sub-
jects consuming the energy drink compared to subjects
consuming the placebo.
In addition to resistance and high intensity anaerobic
exercise, the effects that ED exert on speed/agility perfor-
mance has also been investigated. Collegiate female soccer
players ingested an ED containing 1.3 mg·kgBM
-1
of caf-
feine and 1 gram of taurine or a caffeine and taurine-free
placebo 60 minutes prior to repeated agility t-tests [175].
No difference in agility t-test performance between the ED
and placebo groups was reported. Specifically, the highest
difference reported between the two groups was during
the third set of eight agility t-tests, and the difference
reached only 1.15% between the groups. It is unlikely that
the carbohydrate content alone in ED is responsible for
improvements in resistance exercise performance. In
support of this view, the majority of studies in which
supplemental carbohydrate was ingested prior to a
resistance-training bout did not report improvements
in resistance training performance [176-178].
Conclusion
ED (containing approximately 2 mg·kgBM
-1
caffeine) con-
sumed 45 to 60 minutes prior to anaerobic/resistance
exercise may improve upper- and lower- body total lifting
volume, but has no effect on repeated high intensity sprint
exercise, or on agility performance.
Ingestion prior to endurance exercise
Several studies have investigated the effects of ED inges-
tion prior to aerobic exercise [62,170-172,179]. In the
earliest of these studies, Alford and colleagues [172]
investigated the effects of ingesting a commercial ED on
aerobic endurance. In a repeated measures, crossover
design, young healthy participants ingested 250 mL of a
commercial ED (containing 80 mg of caffeine and 26
grams of carbohydrate), a carbonated water beverage, or
no beverage at all 30 minutes prior to performing an en-
durance exercise bout. Test days for separate treatments
were assessed within a week. Aerobic performance was
analyzed by the amount of time that exercise could be
maintained at 65-75% of maximum heart rate on a cycle
ergometer. Significant improvements in aerobic per-
formance were reported for the commercial ED treat-
ment. Aerobic performance was 8% and 14% longer after
ingesting the commercial ED as compared to the carbo-
nated water and no beverage treatment, respectively.
Table 5 Other potential ergogenic nutrients contained in energy drinks that may affect performance
Ingredient Potential ergogenic value Scientific support
Panax Ginseng Contains ginsenosides which are purported to have
anti-inflammatory, antioxidant, and anticancer effects.
Purported to enhance perceptions of energy, increase
stamina and improve nitrogen balance [96].
Most well-controlled research does not support the ergogenic
effects for ginseng [97-111]. No known effects at dosages
found in ED and ES.
L-Carnitine Involved in shuttling long chain fatty acids into
mitochondria. Purported to promote lipolysis [112].
Limited supportive ergogenic value in athletes or on weight
loss [112]. No known effects at dosages found in ED and ES.
D-Ribose Involved in ATP synthesis. Theoretically,
D-ribose supplementation can increase ATP availability.
Some evidence of improved exercise capacity in clinical
populations [113] but limited evidence that high dose ribose
supplementation affects exercise capacity [114-119]. No
known effects at dosages found in ED and ES.
Beta Alanine Increases muscle carnosine levels, increases muscle
buffering, and attenuates fatigue during high intensity
exercise [120-124].
Growing scientific evidence of improved anaerobic capacity
(2-4 g/d) [125-138]. No known effects at dosages found in ED
and ES.
Inositol Carbohydrate that is not classified as sugar. Involved in
insulin signaling, nerve transmission, serotonin modulation,
and fat oxidation [139].
No known effects at dosages found in ED or ES.
Citrulline Malate Optimizes blood flow via arginine-nitric oxide pathway;
purported to reduce fatigue and buffer acidity during
exercise [140,141].
Some evidence that high dosages (e.g., 6 8 g) can affect
exercise capacity and/or anabolism [142-149]. No known
effects at dosages found in ED and ES.
Quercetin Reported to have antioxidant, anti-inflammatory, antiviral,
and immune-modulatory effects [150].
Several studies indicate that Quercetin supplementation
(e.g., 1 g/d for 7 d) increases maximal aerobic capacity and
time to fatigue [151-166]. No known effects at dosages found
in ED or ES.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 6 of 16
http://www.jissn.com/content/10/1/1
Inoneofonlytwostudiesthathaveinvestigatedthe
effects of ingesting a sugar/carbohydrate-free ED on per-
formance capacity, Candow and colleagues [170] reported
no improvements in high intensity run time-to-exhaustion
performed at 80% of VO
2
max on a treadmill in physically
active college-aged participants. The sugar-free ED con-
tained 2 mg·kgBM
-1
caffeine and was ingested one-hour
prior to the exercise bout [170]. In contrast, Walsh and
colleagues [179] reported significant improvements in
treadmill run time to exhaustion following ingestion of a
carbohydrate-free ED. In this randomized cross-over inves-
tigation, 15 recreationally active participants ingested an
ED 10-minutes prior to engaging in a treadmill run-to
exhaustion test at 70% VO
2
max [179]. The ED utilized in
this study did not contain any carbohydrate, and unlike
other ED products, contained nearly eight grams of the
amino acids L-leucine, L-isoleucine, L-valine, L-arginine
and L-glutamine. Unfortunately, the published study did
not disclose the precise amount of caffeine contained in the
ED, but instead referred to a ~2 g proprietary blendof
caffeine, taurine, and glucoronolactone. The placebo used
as a comparison was sweetened water that was similar in
color and volume. It was reported that participants con-
sumingtheEDwereabletorun12.5%longerthanduring
the placebo treatment [179].
The two most common protocols used to assess
aerobic performance are time to exhaustion at a given
exercise intensity (e.g., exercise at 70% of maximum oxy-
gen uptake until exhaustion) and time trial performance
for a set distance (e.g., 40 km time trial). Time trials
have greater validity than time to exhaustion because
they provide a good physiological simulation of actual
performance and correlate with actual performance
[180,181]. Ivy and colleagues [62] were the first research
group to utilize a time trial component in conjunction
with ED consumption. In this investigation, trained male
and female cyclists completed two trials in a repeated
measures crossover design separated by one week. After
a 12 hour fast, the cyclists ingested a commercially avai-
lable ED providing approximately 2.3 mg·kgBM
-1
caffeine
or an artificially colored, flavored, and sweetened-water
placebo 40-minute prior to the exercise bout. Perfor-
mance during the exercise bout was measured as the
time to complete a standardized amount of work equal
to 1 hr of cycling at 70% of maximal power output.
Results revealed a significant difference between the
treatments in relation to performance with the ED treat-
ment completing the time trial ~4.7% faster than the
placebo treatment [62].
Conclusion
ED containing approximately 2 mg·kgBM
-1
caffeine con-
sumed 10 to 40 minutes prior to aerobic exercise im-
prove cycling and running performance in both trained
cyclists and recreationally active participants. In the one
investigation in which no aerobic performance improve-
ment was reported, the ED (containing 2 mg·kgBM
-1
caf-
feine) was ingested 60-minutes prior to the performance
assessment. In light of the other findings, ingestion of
the caffeine-containing ED 60-minutes prior to the exer-
cise bout may be too long of a period to realize improve-
ments in aerobic exercise performance.
Mood/reaction time/alertness
Reaction time, concentration, alertness, and subjective
feelings of energy/vitality are important in many com-
petitive activities such as hitting a baseball, returning a
serve in tennis, and dodging strikes and kicks in a mixed
martial arts competition. Strategies to improve these
attributes are often sought after by individuals compe-
ting in certain athletic endeavors. Over the past several
years, research has investigated the effects that ED
ingestion has on these (and other) variables.
Seidl and coworkers [31] conducted a study utilizing
three common ingredients (i.e., caffeine, taurine, glucu-
ronolactone) typically found in ED and compared it to a
placebo group. Participants were evaluated at night to
see if ingestion of these nutrients affected mood and
motor function in fatigued participants. Interestingly,
the investigators found that at the end of the experi-
ment, reaction time was significantly longer in the pla-
cebo group, but remained unchanged in the group that
consumed the ED ingredients. Similarly, vitality scores,
feelings of well-being, and social extrovertedness were
all significantly decreased in the placebo group, but did
not change in the ED group [31].
Scholey and colleagues [182] investigated the effects of
an ED (containing primarily caffeine, glucose, ginseng and
ginkgo biloba drink) or a placebo beverage on five aspects
of cognitive performance and mood. Thirty minutes after
consuming ED, two of the five variables (i.e., secondary
memoryand speed of attention) were significantly
improved as compared to the placebo beverage [182].
Other investigators also reported that when caffeine was
combined with carbohydrates in a carbonated beverage,
performance and mood were improved and/or maintained
during fatiguing and cognitively demanding tasks relative
to placebo [183]. Similarly, ED containing caffeine and
glucose have also been shown to enhance event related
potentials (i.e., a measure of brain activity in real time
obtained from an electroencephalogram), which may
translate to improvements in reaction time [184].
Hoffman and colleagues [169] reported that when
male strength/power athletes consumed 120 ml of a
commercially available ED or a placebo, reaction time
and subjective feelings of energy and focus were signifi-
cantly improved in those consuming the ED. Further-
more, the investigators also noted a statistical trend
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 7 of 16
http://www.jissn.com/content/10/1/1
(p=0.06) towards an increase in alertness. In a similar
study, Walsh and colleagues [179] examined the effects
of ingesting an energy matrix(2.05 g of caffeine, tau-
rine, glucuronolactone), amino acids (7.9 g of L-leucine,
L-isoleucine, L-valine, L-arginine and L-glutamine), di-
creatine citrate (5 g), and β-alanine (2.5 g) mixed with
500 ml of water or a placebo) 10-minutes prior to exer-
cise on aerobic performance and subjective measures of
focus, energy, and fatigue in recreationally active male
and females. Results revealed that participants ingesting
the ED increased time to exhaustion while running at
70% of VO
2
max by 12.5% (p = 0.012), they reported
greater focus (p = 0.031), energy (p = 0.016), and less fa-
tigue (p = 0.005) prior to exercise; and, that their ratings
of focus (p = 0.026) and energy (p = 0.004) were greater
10 minutes into exercise [179]. However, no significant
differences in energy, fatigue, and focus were observed
between groups immediately post-exercise [179].
Howard and coworkers [185] evaluated the effects of
acute ingestion of a glucose containing ED on behavioral
control. In this study, 80 participants were randomly
assigned to consume 1.8, 3.6, or 5.4 ml/kg of an ED, a
placebo, or no drink in a counterbalanced manner. Parti-
cipants completed a behavioral control task and subjec-
tive measures of stimulation, sedation, and mental
fatigue before and 30-minutes after ingestion of the
assigned drinks. Results revealed that those consuming
the ED decreased reaction times on the behavioral con-
trol task, increased subjective ratings of stimulation and
decreased ratings of mental fatigue. The greatest
improvements in reaction times and subjective measures
were observed with the lower dose and improvements
diminished as the dose increased. Earlier research con-
ducted by Alford and associates [172] supported these
findings by demonstrating that individuals ingesting 250
ml of this same ED had significantly better reaction time,
concentration, memory, and subjective alertness com-
pared to a placebo. Smit and coworkers [183] suggested
that caffeine is most likely the primary ingredient that
improves mood and performance during fatiguing and
cognitively demanding tasks, with carbohydrates playing
a minor role. However, caffeine and carbohydrate may
act in a synergistic manner [182]. To support this view,
a recent paper by Pettitt et al [186] reported that while
ingestion of an ED prior to exercise affected aerobic me-
tabolism during and following cycling exercise, the sec-
ondary ingredients found in the ED had no additive
effects.
Conclusion
To date, most studies on ED have reported improve-
ments in mood, reaction time, and/or markers of alert-
ness, even though the relative importance of the various
ingredients is not fully understood. The primary ergogenic
valueappearstobeduetothecaffeine and/or carbohydrate
contained in these drinks. Individuals looking to enhance
reaction time, mental alertness, and/or focus may benefit
from consuming an ED prior to exercise.
Energy drinks and their role in energy
expenditure and weight loss
As shown in Table 4, ED and some commercial be-
verages designed to increase metabolism typically contain
a number of stimulants (e.g., caffeine, Guarana, Green Tea,
synephrine,Yerbamate,Yohimbine, Tyramine, Vinocetine,
etc.). Several low-calorie ED and beverages have been
marketed as thermogenic blendswith a focus on increa-
sing metabolism. Theoretically, ingestion of ED prior to
exercise may increase energy expenditure which over time
could help manage and/or promote weight loss. In support
of this theory, studies have shown that ingestion of caffeine
(e.g., 200-500 mg) can increase acute (1-24 hours) energy
expenditure [187-193], chronic (28 days) energy expen-
diture [194], and elevate plasma free-fatty acid and glycerol
levels [187,194,195]. Collectively, these findings suggest that
the stimulant properties of caffeine contained in ED can
elevate an individuals metabolic rate as well as elevate the
rate of lipolysis in the body. However, these studies used
various types of caffeine/stimulant/vitamin-enriched cof-
fee [189-193], a caffeine/stimulant blend supplement
[187,189,193], and various calorie-free thermogenic ED
[190,194-197]. Additionally, the dosage of caffeine used in
some of these beverages that are marketed as a thermo-
genic supplements is typically higher (e.g., 200-500 mg)
than the concentrations found in ED and ES marketed for
increasing athletic performance or alertness (i.e., about
80 200 mg). With this said, there is some data that indi-
cates that acute ingestion of ED has been shown to en-
hance energy expenditure, metabolic rate, catecholamine
secretion, and/or lipolysis [187,198]
In terms of weight loss, Roberts and colleagues [194]
reported that 28 days of consumption of a calorie free
ED (336 ml/day) promoted small (i.e., 18.9 ± 1.5 to 18.3
± 1.5 kg) but statistically significant (p<0.05) reductions
in fat mass compared to controls (i.e., 18.1 ± 1.3 to 18.4
3± 1.2 kg). Similarly, Stout and associates [199] evaluated
the effects of consuming an ED or placebo 15-minutes
prior to exercise training and ad-libitum on non-training
days for 10-weeks on changes in body composition and
fitness. Results revealed that those consuming the ED
experienced greater changes in fat mass (-6.6% vs.
-0.35%, p<0.05), peak aerobic capacity (+13.8% vs. 5.4%,
p<0.01), and treadmill time to exhaustion (+19.7% vs.
14.0%, p<0.01). These findings suggest that consumption
of ED during training and/or weight loss may provide
some additive ergogenic benefits. However, it should be
noted that recent review on ED by Higgins and asso-
ciates [200] found that many of the commonly used
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 8 of 16
http://www.jissn.com/content/10/1/1
additional ingredients (e.g., Ma Huang, willow bark,
synephrine, calcium, cayenne/black pepper extracts) that
are contained in the thermogenic blendsof several of
these products are not contained in some of the most
commonly used ED. It is also important to note that
daily consumption of high calorie ED could promote
weight gain. Consequently, additional research is neces-
sary to determine whether ingesting low-calorie ED or
ES may affect training adaptations and/or weight loss.
Conclusion
Consumption of low calorie ED and thermogenic be-
verages have been reported to increase resting energy
expenditure and fat metabolism on an acute basis. Pre-
liminary studies suggest that ingesting some types of ED
and thermogenic beverages prior to exercise during
training could promote positive adaptations in body
composition. However, more research is needed to de-
termine whether daily use of ED would affect long-term
energy balance and body composition.
Safety considerations
ED have had a negative connotation in the media and
more recently medical community, mostly related to po-
tential concerns about excessive caffeine intake [201,202]
and/or potential deleterious effects of mixing ED with
alcohol [203]. While safety concerns and use of alcohol go
beyond the scope of this paper, the reader is referred to a
recent viewpoint published in the Journal of the American
Medical Association related to safety concerns of mixing
ED with alcohol [203]. In terms of use of ED in the tra-
ditional sense, most concerns have been based on case
studies or adverse event reports that have serve only to
document a potential association, but does not establish
causality. In reality, there are currently only a few studies
(acute or long term) that have investigated the side effects
of ED [204-209]. There appear to be two primary active
nutrients in most ED and ES (i.e., carbohydrate and caf-
feine) that may possess safety concerns in some popula-
tions. Many ED contain 25 50 g of simple sugars,
therefore, ingestion of ED prior to exercise are likely to
rapidly increase insulin in order to maintain normal blood
glucose levels. For this reason, diabetics and pre-diabetics
should avoid high glycemic load ED or consider consu-
ming low carbohydrate versions of ED [201,202].
Very often, ED also contain various stimulants with
the most common being caffeine. Some concern has
been raised about excessive caffeine intake that could be
obtained from consuming too many ED and/or from a
lack of knowledge that that some ingredients contained
in ED may contain caffeine [201,202]. Currently in the
United States, the FDA has regulated the limit of caf-
feine in soft drinks to 0.02 percent (10mg/oz.) of the
product, but this is not currently enforced for ED or ES.
As of December 2012, the US-FDA along with the US
Congress has begun to study products marketed as ED
or ES, however no formal new guidelines have been pub-
lished. The Nutrition Facts Panel on food labels are not
required to always list caffeine since it is not a nutrient.
However, if caffeine is added to a food, it must then be
listed [210]; therefore many individuals may consume
more caffeine than they realize [201,202]. In Canada,
caffeine levels are limited to 180 mg per drink [211].
The caffeine content of common ED and ES has been
reported to range from about 100 to 286 mg [202]. As a
comparison, the average cup of coffee or contains be-
tween 40 and 150 mg caffeine, while a 20 oz. cup of
Starbucks regular drip coffee has been found to contain
as much as 480 mg of caffeine [212].
The potential side effects of caffeine include: insomnia,
nervousness, restlessness, gastric irritation, nausea, vomi-
ting, tachycardia, tremors, and anxiety; which have been
reported at doses as low as 250 to 300 mg [5,201-204,209].
Caffeine availability is ubiquitous and it is one of the most
extensively studied substances in the food supply with a
long history as generally regarded as safe when consumed
in moderation [61]. However, all substances may be toxic
under the right conditions, with toxicity being a function of
the interaction of many physiologic variables that include
the following: acute and chronic dosing, route of adminis-
tration, genetics, age, sex, environment, and intrinsic health
of the individual being exposed. Young adults have been
found to have subclinical coronary atherosclerosis [213]. In
addition, post-mortem assessment of sudden cardiac death
in young persons (<35 years) reveals a variety of anatomic
abnormalities of the coronary arteries, myocardium, valves
and the conduction system [214]. Such unknown pre-
existing risk factors may increase the risk of adverse events,
particularly cardiovascular ones, in individuals consuming
EDs, due to underlying disease. In fact, even water can be
toxic given certain conditions with an LD
50
(lethal acute
dose for 50 percent in test species) of greater than 90 mL/
kg in rats [215]. It is possible to overdose on caffeine and
there are a handful of case reports in the literature
[5,209,216-218]. A lethal dose of caffeine has been typically
in excess of 5 g [217], which equates to about 42 cups of
coffee at 120 mg of caffeine per cup. Sepkowitz [201] re-
cently suggested that an intake of 3 grams of caffeine
(equivalent to ingesting 12 or so highly caffeinated ED
within a few hours) could elicit significant adverse effects.
TheaveragecaffeineperservinginmostEDandESrange
between 75 and 200 mg, an amount similar to the caffeine
found in a premium cup of coffee [202].
Nawrot and colleagues [219] stated that in a healthy adult
population, up to 400 mg of caffeine daily was not asso-
ciated with any adverse effects. In another review, Higdon
et al. [220] presented data in children stating no adverse
effects were seen with doses under 3 mg·kgBM
-1
·day
-1
.As
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 9 of 16
http://www.jissn.com/content/10/1/1
with most drugs, the exact amount of caffeine where side
effects will occur varies from person to person based on
genetics, age, liver cytochrome P450-CYP1A2 isozyme
function, concurrent medications or substances that may
affect hepatic metabolism, body mass, and sensitivity.
Additionally, it is unknown whether inclusion of other
stimulants in ED and/or ES may increase or decrease the
threshold for experiencing side effects. For this reason,
some groups do not recommend ED or ES for athletes
participating in exercise lasting less than 1 hour [200],
despite the admission of inadequate long-term data. The
longest duration studies on ED or ES we were able to find
was 10 weeks and these studies did not report any change
in clinical safety markers [199,206]. Nevertheless, since ED
and ES often contain other stimulants that can have a
synergistic effect with caffeine, more research is needed to
determine the long-term effects of habitual intake of ED
and ES before definitive conclusions can be drawn.
Several reports have expressed concern about the
safety of ED [5,200,205,221]. For example, Worthley and
associates [222] tested 50 young male and female adults
one hour before and one hour after consuming 250 ml
of a sugar-free ED containing approximately 80 mg of
caffeine. The investigators found that mean arterial pres-
sure increased by approximately 3.8 mmHg while resting
heart rate was not affected. Additionally, platelet aggre-
gation increased by 13.7% compared to only a 0.3%
change in the control group while endothelial function
decreased. The researchers noted that the component of
the ED that was associated with these results was not
clear. However, they suggested that since endothelial
dysfunction and impaired platelet function are associated
with elevated glucose levels, it is possible that glucuro-
nolactone contained in the ED might have contributed
to the observed detrimental effects of energy drinks
[222]. More research is needed to corroborate these
findings as well as to determine whether these acute
changes would pose any long-term health risk.
Bichler and cohorts [26] investigated a combination of
caffeine and taurine (two common ingredients in ED) in
a double-blind study of college students. Subjects con-
sumed either caffeine and taurine pills or a placebo and
then completed a memory assessment while heart rate
and blood pressure were monitored. The combination
caused a significant decline in heart rate and an increase
in mean arterial blood pressure. Steinke et al. [223] stu-
died 15 healthy adults who abstained from caffeine for
48 hours prior to and during the study in addition to
being fasted overnight. Baseline measurements of blood
pressure and heart rate were measured. On day one of
the study, each participant consumed 500 mL (2 cans) of
an ED and measurements were repeated 30 minutes,
1 hour, 2 hours, 3 hours, and 4 hours later. Participants
also drank 500 mL of the ED drink daily for the next 5
days. The experiment was then repeated after 7-days.
The investigators found that maximum mean heart rate
occurred at 4 hours with significant increases of 7.8%
and 11.0% on days 1 and 7, respectively. Blood pressures
were increased approximately 7% after acute ingestion of
the ED on day 1 (significant increase) but no differences
were seen on day 7. Finally, in a case report, Usman and
coworkers [221] reported that a young boy presented
with palpitations and high blood pressure after con-
sumption of an ED containing carbohydrate (40 g), so-
dium citrate, taurine (124 mg), caffeine, inositol (17 mg),
Panax ginseng (6.98 mg), and other nutrients. The
tachycardia and hypertension returned to normal after
discontinuation of ED consumption.
Conclusion
Individuals with certain medical conditions (e.g., meta-
bolic syndrome or diabetes mellitus) should avoid con-
sumption of high glycemic drinks and/or foods and
therefore should not consume the high calorie versions
of ED. It would be prudent for individuals with known
cardiovascular disease to avoid altogether their use of
ED and/or ES, or other products with known cardio-
stimulant effects. While ED containing caffeine and other
stimulants may have negative effects upon health and
cardiac parameters in individuals with such pre-existing
health conditions, the current evidence (although small)
suggests that consumption of ED and ES are safe in
healthy populations and similar to ingesting other foods
and beverages containing caffeine. Finally, although it is
estimated that only 1% of all dietary supplement adverse
events are reported to FDA [224], given the number of
servings of these products that are consumed daily, the
rate of adverse events appears low in the population of
consumers. Nevertheless, it is acknowledged that addi-
tional short- and long-term studies are needed to better
determine any factors that increase the risk for adverse
events. Additionally, since ED often contain several nutri-
ents that contain caffeine and/or other stimulants, care
should be taken to make sure that an excessive number of
ED are not consumed within a short period of time.
Conclusions and recommendations
Based on a review of the available scientific and medical
literature related to the safety and efficacy of the use of
ED or ES, the Research Committee of the Society makes
the following conclusions and recommendations.
1. Although ED and ES contain a number of nutrients
that are purported to affect mental and/or physical
performance, the primary ergogenic nutrients in most
ED and ES appear to be carbohydrate and/or caffeine.
2. The ergogenic value of caffeine on mental and
physical performance has been well-established but
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 10 of 16
http://www.jissn.com/content/10/1/1
the potential additive benefits of other nutrients
contained in ED and ES remains to be determined.
3. Consuming ED 10-60 minutes before exercise can
improve mental focus, alertness, anaerobic
performance, and/or endurance performance.
4. Many ED and ES contain numerous ingredients;
these products in particular merit further study to
demonstrate their safety and potential effects on
physical and mental performance.
5. There is some limited evidence that consumption of
low-calorie ED during training and/or weight loss
trials may provide ergogenic benefit and/or promote
a small amount of additional fat loss. However,
ingestion of higher calorie ED may promote weight
gain if the energy intake from consumption of ED is
not carefully considered as part of the total daily
energy intake.
6. Athletes should consider the impact of ingesting high
glycemic load carbohydrates on metabolic health,
blood glucose and insulin levels, as well as the effects
of caffeine and other stimulants on motor skill
performance.
7. Children and adolescents should only consider use of
ED or ES with parental approval after consideration
of the amount of carbohydrate, caffeine, and other
nutrients contained in the ED or ES and a thorough
understanding of the potential side effects.
8. Indiscriminant use of ED or ES, especially if more
than one serving per day is consumed, may lead to
adverse events and harmful side effects.
9. Diabetics and individuals with pre-existing
cardiovascular, metabolic, hepatorenal, and
neurologic disease who are taking medications that
may be affected by high glycemic load foods, caffeine,
and/or other stimulants should avoid use of ED
and/or ES unless approved by their physician.
Competing interests
BC has received university and private sector funded grants to conduct
research on several dietary supplements and has received compensation for
speaking at conferences and writing lay articles/books about dietary
supplements. PLB has received compensation for contributing to edited
books in relation to sports nutrition. CW has received academic and industry
funding related to dietary supplements and honoraria from speaking
engagements on the topic. LT has received academic and industry funding
related to dietary supplements and honoraria for speaking at conferences.
MTN declares no competing interests. MG has received academic and
industry funding related to dietary supplementation but declares no
competing interests regarding the contents of this manuscript. TNZ has
received funding from the dietary supplement industry to conduct clinical
research through The Center for Applied Health Sciences, has consulted for
several dietary supplement companies, and currently serves as a scientific
advisor to Biotest Laboratories. HLL has received funding from industry to
conduct clinical research through The Center for Applied Health Sciences,
has consulted for multiple dietary supplement and medical food companies,
and currently serves as scientific and medical advisor to Nordic Naturals, Inc.
JRS serves as a science advisor for Abbott Nutrition. SS has not competing
interest to declare. RC has no competing interests to declare. DSK works for
a Contract Research Organization that receives funding for clinical trials from
the pharmaceutical and nutritional industries, serves as a Nutrition
Consultant currently to the United States Tennis Association (USTA),
Boca Raton, Florida, and serves as the also as the Florida International
University, Department of Athletics, Sports Nutritionist. JA is a Sports Science
Advisor to VPX/Redline in Weston FL. RBK has received external funding
from industry through the institutions he has been affiliated with to conduct
exercise and nutrition research, has served as a legal expert on exercise and
nutrition related cases, and currently serves as a scientific advisor for
Woodbolt International.
Authorscontributions
RBK prepared and delivered the presentation on energy drinks at the 2011
International Society of Sports Nutrition (ISSN) National meeting. BC, CW, LT,
MTN, and MG developed the presentation into a draft of a position stand for
review and editing by RBK. The final draft was then reviewed and edited by
TZ, HL, JRH, JRS, SS, RC, DSK and JA. RBK incorporated recommendations
into a final draft which was then reviewed, approved, and adopted as the
official position of the ISSN by the Research Committee. All authors read
and approved the final manuscript.
Author details
1
Exercise and Performance Nutrition Laboratory, Dept. of Physical Education
and Exercise Science, University of South Florida, 4202 E. Fowler Avenue, PED
214, Tampa, FL 33620, USA.
2
Human Performance Laboratory, University of
Mary Hardin-Baylor, Belton, TX 76513, USA.
3
Department of Health, Human
Performance, and Recreation, Baylor University, Box 97313, Waco, TX 76798,
USA.
4
Department of Health and Human Performance, University of St.
Thomas, St. Paul, MN 55105, USA.
5
Exercise & Sport Nutrition Lab,
Department of Health & Kinesiology, Texas A&M University, College Station,
Texas, TX 77843-4243, USA.
6
The Center for Applied Health Sciences, Stow,
OH 44224, USA.
7
Institute of Exercise Physiology and Wellness, Department
of Sport and Exercise Science, University of Central Florida, Orlando, FL
32816, USA.
8
Medical Surveillance and Risk Management, Shire HGT, 300
Shire Way, Lexington, MA 02421, USA.
9
Collins, McDonald & Gann, PC,
Mineola, NY, USA.
10
Miami Research Associates, Endocrinology & Nutrition
Department, 6141 Sunset Drive - Suite 301, Miami, FL 33143, USA.
11
Farquhar
College of Arts and Sciences, Nova Southeastern University, Fort Lauderdale,
FL, USA.
Received: 28 December 2012 Accepted: 31 December 2012
Published: 3 January 2013
References
1. Froiland K, Koszewski W, Hingst J, Kopecky L: Nutritional supplement use
among college athletes and their sources of information. Int J Sport Nutr
Exerc Metab 2004, 14:104120.
2. Hoffman: Caffeine and Energy Drinks. Strength Cond J 2010, 32:1520.
3. Hoffman JR, Faigenbaum AD, Ratamess NA, Ross R, Kang J, Tenenbaum G:
Nutritional supplementation and anabolic steroid use in adolescents.
Med Sci Sports Exerc 2008, 40:1524.
4. Petroczi A, Naughton DP, Pearce G, Bailey R, Bloodworth A, McNamee M:
Nutritional supplement use by elite young UK athletes: fallacies of
advice regarding efficacy. J Int Soc Sports Nutr 2008, 5:22.
5. Wolk BJ, Ganetsky M, Babu KM: Toxicity of energy drinks. Curr Opin Pediatr
2012, 24:243251.
6. Kerksick C, Harvey T, Stout J, Campbell B, Wilborn C, Kreider R, Kalman D,
Ziegenfuss T, Lopez H, Landis J, et al:International Society of Sports
Nutrition position stand: nutrient timing. J Int Soc Sports Nutr 2008, 5:17.
7. Goldstein ER, Ziegenfuss T, Kalman D, Kreider R, Campbell B, Wilborn C,
Taylor L, Willoughby D, Stout J, Graves BS, et al:International society of
sports nutrition position stand: caffeine and performance. J Int Soc Sports
Nutr 2010, 7:5.
8. Bonati M, Latini R, Galletti F, Young JF, Tognoni G, Garattini S:
Caffeine disposition after oral doses. Clin Pharmacol Ther 1982, 32:98106.
9. Graham TE, Hibbert E, Sathasivam P: Metabolic and exercise endurance
effects of coffee and caffeine ingestion. J Appl Physiol 1998, 85:883889.
10. McLellan TM, Bell DG: The impact of prior coffee consumption on the
subsequent ergogenic effect of anhydrous caffeine. Int J Sport Nutr Exerc
Metab 2004, 14:698708.
11. Kovacs EM, Stegen J, Brouns F: Effect of caffeinated drinks on substrate
metabolism, caffeine excretion, and performance. J Appl Physiol 1998,
85:709715.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 11 of 16
http://www.jissn.com/content/10/1/1
12. Oka H, Suzuki S, Suzuki H, Oda T: Increased urinary excretion of L-xylulose
in patients with liver cirrhosis. Clin Chim Acta 1976, 67:131136.
13. Jeukendrup A, Brouns F, Wagenmakers AJ, Saris WH: Carbohydrate-electrolyte
feedings improve 1 h time trial cycling performance. Int J Sports Med 1997,
18:125129.
14. Jeukendrup AE: Carbohydrate intake during exercise and performance.
Nutrition 2004, 20:669677.
15. Coyle EF, Coggan AR, Hemmert MK, Ivy JL: Muscle glycogen utilization
during prolonged strenuous exercise when fed carbohydrate. J Appl
Physiol 1986, 61:165172.
16. Jeukendrup AE, Jentjens R: Oxidation of carbohydrate feedings during
prolonged exercise: current thoughts, guidelines and directions for
future research. Sports Med 2000, 29:407424.
17. Kreider RB, Wilborn CD, Taylor L, Campbell B, Almada AL, Collins R, Cooke M,
Earnest CP, Greenwood M, Kalman DS, et al:ISSN exercise & sport nutrition
review: research & recommendations. J Int Soc Sports Nutr 2010, 7:7.
18. Rodriguez NR, Di Marco NM, Langley S: American College of Sports
Medicine position stand. Nutrition and athletic performance. Med Sci
Sports Exerc 2009, 41:709731.
19. Murray R, Bartoli W, Stofan J, Horn M, Eddy D: A comparison of the gastric
emptying characteristics of selected sports drinks. Int J Sport Nutr 1999,
9:263274.
20. Maughan RJ, Leiper JB: Limitations to fluid replacement during exercise.
Can J Appl Physiol 1999, 24:173187.
21. Franconi F, Loizzo A, Ghirlanda G, Seghieri G: Taurine supplementation
and diabetes mellitus. Curr Opin Clin Nutr Metab Care 2006, 9:3236.
22. Dawson R Jr, Biasetti M, Messina S, Dominy J: The cytoprotective role of
taurine in exercise-induced muscle injury. Amino Acids 2002, 22:309324.
23. Zhang M, Izumi I, Kagamimori S, Sokejima S, Yamagami T, Liu Z, Qi B:
Role of taurine supplementation to prevent exercise-induced oxidative
stress in healthy young men. Amino Acids 2004, 26:203207.
24. Obrosova IG, Stevens MJ: Effect of dietary taurine supplementation on GSH and
NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic
precataractous lens. Invest Ophthalmol Vis Sci 1999, 40:680688.
25. Bakker AJ, Berg HM: Effect of taurine on sarcoplasmic reticulum function
and force in skinned fast-twitch skeletal muscle fibres of the rat. J Physiol
2002, 538:185194.
26. Bichler A, Swenson A, Harris MA: A combination of caffeine and taurine
has no effect on short term memory but induces changes in heart rate
and mean arterial blood pressure. Amino Acids 2006, 31:471476.
27. Galloway SD, Talanian JL, Shoveller AK, Heigenhauser GJ, Spriet LL:
Seven days of oral taurine supplementation does not increase muscle
taurine content or alter substrate metabolism during prolonged exercise
in humans. J Appl Physiol 2008, 105:643651.
28. Matsuzaki Y, Miyazaki T, Miyakawa S, Bouscarel B, Ikegami T, Tanaka N:
Decreased taurine concentration in skeletal muscles after exercise for
various durations. Med Sci Sports Exerc 2002, 34:793797.
29. Rutherford JA, Spriet LL, Stellingwerff T: The effect of acute taurine
ingestion on endurance performance and metabolism in well-trained
cyclists. Int J Sport Nutr Exerc Metab 2010, 20:322329.
30. Ward RJ, Francaux M, Cuisinier C, Sturbois X, De Witte P: Changes in
plasma taurine levels after different endurance events. Amino Acids 1999,
16:7177.
31. Seidl R, Peyrl A, Nicham R, Hauser E: A taurine and caffeine-containing
drink stimulates cognitive performance and well-being. Amino Acids
2000, 19:635642.
32. GoodmanCA,HorvathD,StathisC,MoriT,CroftK,MurphyRM,HayesA:Taurine
supplementation increases skeletal muscle force production and protects
muscle function during and after high-frequency in vitro stimulation. JAppl
Physiol 2009, 107:144154.
33. Wang FR, Dong XF, Tong JM, Zhang XM, Zhang Q, Wu YY: Effects of
dietary taurine supplementation on growth performance and immune
status in growing Japanese quail (Coturnix coturnix japonica). Poult Sci
2009, 88:13941398.
34. Pierno S, De Luca A, Camerino C, Huxtable RJ, Camerino DC: Chronic
administration of taurine to aged rats improves the electrical and contractile
properties of skeletal muscle fibers. J Pharmacol Exp Ther 1998, 286:11831190.
35. Warburton DM, Bersellini E, Sweeney E: An evaluation of a caffeinated
taurine drink on mood, memory and information processing in healthy
volunteers without caffeine abstinence. Psychopharmacology (Berl) 2001,
158:322328.
36. Jorm AF, Rodgers B, Christensen H: Use of medications to enhance memory in a
large community sample of 60-64 year olds. Int Psychogeriatr 2004, 16:209217.
37. Elsabagh S, Hartley DE, File SE: Limited cognitive benefits in Stage +2
postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
J Psychopharmacol 2005, 19:173181.
38. Walesiuk A, Trofimiuk E, Braszko JJ: Gingko biloba extract diminishes
stress-induced memory deficits in rats. Pharmacol Rep 2005, 57:176187.
39. Stoll S, Scheuer K, Pohl O, Muller WE: Ginkgo biloba extract (EGb 761)
independently improves changes in passive avoidance learning and
brain membrane fluidity in the aging mouse. Pharmacopsychiatry 1996,
29:144149.
40. Grevet EH, Tietzmann MR, Shansis FM, Hastenpflugl C, Santana LC, Forster L,
Kapczinskil F, Izquierdo I: Behavioural effects of acute phenylalanine and
tyrosine depletion in healthy male volunteers. J Psychopharmacol 2002,
16:5155.
41. Mahoney CR, Castellani J, Kramer FM, Young A, Lieberman HR: Tyrosine
supplementation mitigates working memory decrements during cold
exposure. Physiol Behav 2007, 92:575582.
42. Chinevere TD, Sawyer RD, Creer AR, Conlee RK, Parcell AC:
Effects of L-tyrosine and carbohydrate ingestion on endurance exercise
performance. J Appl Physiol 2002, 93:15901597.
43. Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ:
Tyrosine improves cognitive performance and reduces blood pressure in
cadets after one week of a combat training course. Brain Res Bull 1999,
48:203209.
44. Salter CA: Dietary tyrosine as an aid to stress resistance among troops.
Mil Med 1989, 154:144146.
45. Smith ML, Hanley WB, Clarke JT, Klim P, Schoonheyt W, Austin V,
Lehotay DC: Randomised controlled trial of tyrosine supplementation on
neuropsychological performance in phenylketonuria. Arch Dis Child 1998,
78:116121.
46. Magill RA, Waters WF, Bray GA, Volaufova J, Smith SR, Lieberman HR,
McNevin N, Ryan DH: Effects of tyrosine, phentermine,
caffeine D-amphetamine, and placebo on cognitive and motor
performance deficits during sleep deprivation. Nutr Neurosci 2003,
6:237246.
47. Waters WF, Magill RA, Bray GA, Volaufova J, Smith SR, Lieberman HR, Rood J,
Hurry M, Anderson T, Ryan DH: A comparison of tyrosine against placebo,
phentermine, caffeine, and D-amphetamine during sleep deprivation.
Nutr Neurosci 2003, 6:221235.
48. OBrien C, Mahoney C, Tharion WJ, Sils IV, Castellani JW: Dietary tyrosine
benefits cognitive and psychomotor performance during body cooling.
Physiol Behav 2007, 90:301307.
49. Wiesel FA, Edman G, Flyckt L, Eriksson A, Nyman H, Venizelos N,
Bjerkenstedt L: Kinetics of tyrosine transport and cognitive functioning in
schizophrenia. Schizophr Res 2005, 74:8189.
50. Struder HK, Hollmann W, Platen P, Donike M, Gotzmann A, Weber K:
Influence of paroxetine, branched-chain amino acids and tyrosine on
neuroendocrine system responses and fatigue in humans. Horm Metab
Res 1998, 30:188194.
51. Jager R, Purpura M, Kingsley M: Phospholipids and sports performance.
J Int Soc Sports Nutr 2007, 4:5.
52. Warber JP, Patton JF, Tharion WJ, Zeisel SH, Mello RP, Kemnitz CP,
Lieberman HR: The effects of choline supplementation on physical
performance. Int J Sport Nutr Exerc Metab 2000, 10:170181.
53. Turner EH, Loftis JM, Blackwell AD: Serotonin a la carte: supplementation
with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther 2006,
109:325338.
54. Chaouloff F, Laude D, Elghozi JL: Physical exercise: evidence for differential
consequences of tryptophan on 5-HT synthesis and metabolism in central
serotonergic cell bodies and terminals. J Neural Transm 1989, 78:121130.
55. Leu-Semenescu S, Arnulf I, Decaix C, Moussa F, Clot F, Boniol C, Touitou Y,
Levy R, Vidailhet M, Roze E: Sleep and rhythm consequences of a
genetically induced loss of serotonin. Sleep 2010, 33:307314.
56. Freeman MP, Helgason C, Hill RA: Selected integrative medicine
treatments for depression: considerations for women. J Am Med Womens
Assoc 2004, 59:216224.
57. Larzelere MM, Wiseman P: Anxiety, depression, and insomnia.
Prim Care 2002, 29:339360. vii.
58. Thachil AF, Mohan R, Bhugra D: The evidence base of complementary and
alternative therapies in depression. J Affect Disord 2007, 97:2335.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 12 of 16
http://www.jissn.com/content/10/1/1
59. Hayashi Y, Jacob-Vadakot S, Dugan EA, McBride S, Olexa R, Simansky K,
Murray M, Shumsky JS: 5-HT precursor loading, but not 5-HT receptor
agonists, increases motor function after spinal cord contusion in adult
rats. Exp Neurol 2010, 221:6878.
60. Yamamoto T, Newsholme EA: Diminished central fatigue by inhibition of
the L-system transporter for the uptake of tryptophan. Brain Res Bull
2000, 52:3538.
61. Heckman MA, Weil J, Gonzalez de Mejia E: Caffeine (1, 3, 7-trimethylxanthine) in
foods: a comprehensive review on consumption, functionality, safety, and
regulatory matters. J Food Sci 2010, 75:R7787.
62. Ivy JL, Kammer L, Ding Z, Wang B, Bernard JR, Liao YH, Hwang J: Improved
cycling time-trial performance after ingestion of a caffeine energy drink.
Int J Sport Nutr Exerc Metab 2009, 19:6178.
63. Goldstein E, Jacobs PL, Whitehurst M, Penhollow T, Antonio J:
Caffeine enhances upper body strength in resistance-trained women.
J Int Soc Sports Nutr 2010, 7:18.
64. Del Coso J, Muñoz-Fernández VE, Muñoz G, Fernández-Elías VE, Ortega JF,
Hamouti N, Barbero JC, Muñoz-Guerra J: Effects of a Caffeine-Containing
Energy Drink on Simulated Soccer Performance. PLoS One 2012, 7:e31380.
65. Del Coso J, Salinero JJ, Gonzalez-Millan C, Abian-Vicen J, Perez-Gonzalez B:
Dose response effects of a caffeine-containing energy drink on muscle
performance: a repeated measures design. J Int Soc Sports Nutr 2012, 9:21.
66. Berube-Parent S, Pelletier C, Dore J, Tremblay A: Effects of encapsulated
green tea and Guarana extracts containing a mixture of
epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and
fat oxidation in men. Br J Nutr 2005, 94:432436.
67. Belza A, Toubro S, Astrup A: The effect of caffeine, green tea and tyrosine
on thermogenesis and energy intake. Eur J Clin Nutr 2009, 63:5764.
68. Eichenberger P, Colombani PC, Mettler S: Effects of 3-week consumption
of green tea extracts on whole-body metabolism during cycling exercise
in endurance-trained men. Int J Vitam Nutr Res 2009, 79:2433.
69. Venables MC, Hulston CJ, Cox HR, Jeukendrup AE: Green tea extract
ingestion, fat oxidation, and glucose tolerance in healthy humans.
Am J Clin Nutr 2008, 87:778784.
70. Eichenberger P, Mettler S, Arnold M, Colombani PC: No Effects of Three-
week Consumption of a Green Tea Extract on Time Trial Performance in
Endurance-trained Men. Int J Vitam Nutr Res 2010, 80:5464.
71. Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML,
Jois M, Sinclair AJ, Begg DP, Wark JD, et al:Green tea, black tea, and
epigallocatechin modify body composition, improve glucose tolerance,
and differentially alter metabolic gene expression in rats fed a high-fat
diet. Nutr Res 2009, 29:784793.
72. Hursel R, Westerterp-Plantenga MS: Green tea catechin plus caffeine
supplementation to a high-protein diet has no additional effect on body
weight maintenance after weight loss. Am J Clin Nutr 2009, 89:822830.
73. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanidkulchai BO,
Auvichayapat N, Thinkhamrop B, Kunhasura S, Wongpratoom S, Sinawat S,
Hongprapas P: Effectiveness of green tea on weight reduction in obese
Thais: A randomized, controlled trial. Physiol Behav 2008, 93:486491.
74. Diepvens K, Kovacs EM, Nijs IM, Vogels N, Westerterp-Plantenga MS:
Effect of green tea on resting energy expenditure and substrate oxidation
during weight loss in overweight females. Br J Nutr 2005, 94:10261034.
75. Diepvens K, Westerterp KR, Westerterp-Plantenga MS: Obesity and
thermogenesis related to the consumption of caffeine, ephedrine,
capsaicin, and green tea. Am J Physiol Regul Integr Comp Physiol 2007,
292:R7785.
76. Murase T, Haramizu S, Shimotoyodome A, Tokimitsu I, Hase T:
Green tea extract improves running endurance in mice by stimulating
lipid utilization during exercise. Am J Physiol Regul Integr Comp Physiol
2006, 290:R15501556.
77. Fugh-Berman A, Myers A: Citrus aurantium, an ingredient of dietary
supplements marketed for weight loss: current status of clinical and
basic research. Exp Biol Med (Maywood) 2004, 229:698704.
78. Haller CA, Benowitz NL, Jacob P 3rd: Hemodynamic effects of ephedra-free
weight-loss supplements in humans. Am J Med 2005, 118:9981003.
79. KimGS,ParkHJ,WooJH,KimMK,KohPO,MinW,KoYG,KimCH,WonCK,Cho
JH: Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling
pathway in 3T3-L1 cells. BMC Complement Altern Med 2012, 12:31.
80. Peixoto JS, Comar JF, Moreira CT, Soares AA, de Oliveira AL, Bracht A, Peralta RM:
Effects of Citrus aurantium (bitter orange) fruit extracts and p-synephrine on
metabolic fluxes in the rat liver. Molecules 2012, 17:58545869.
81. Preuss HG, DiFerdinando D, Bagchi M, Bagchi D: Citrus aurantium as a
thermogenic, weight-reduction replacement for ephedra: an overview.
J Med 2002, 33:247264.
82. Stohs SJ, Preuss HG, Keith SC, Keith PL, Miller H, Kaats GR: Effects of
p-synephrine alone and in combination with selected bioflavonoids on
resting metabolism, blood pressure, heart rate and self-reported mood
changes. Int J Med Sci 2011, 8:295301.
83. Pittler MH, Ernst E: Dietary supplements for body-weight reduction:
a systematic review. Am J Clin Nutr 2004, 79:529536.
84. Pittler MH, Schmidt K, Ernst E: Adverse events of herbal food supplements
for body weight reduction: systematic review. Obes Rev 2005, 6:93111.
85. Kang YR, Lee HY, Kim JH, Moon DI, Seo MY, Park SH, Choi KH,
Kim CR, Kim SH, Oh JH, et al:Anti-obesity and anti-diabetic effects of
Yerba Mate (Ilex paraguariensis) in C57BL/6J mice fed a high-fat diet.
Lab Anim Res 2012, 28:2329.
86. Riley AJ: Yohimbine in the treatment of erectile disorder. Br J Clin Pract
1994, 48:133136.
87. Gupta RS, Sharma R, Sharma A, Bhatnager AK, Dobhal MP, Joshi YC, Sharma MC:
Effect of Alstonia scholaris bark extract on testicular function of Wistar rats.
Asian J Androl 2002, 4:175178.
88. Porst H: Thefutureoferectiledysfunction(ED).Arch Esp Urol 2010, 63:740747.
89. Kucio C, Jonderko K, Piskorska D: Does yohimbine act as a slimming drug?
Isr J Med Sci 1991, 27:550556.
90. Sax L: Yohimbine does not affect fat distribution in men. Int J Obes 1991,
15:561565.
91. deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern
M, Shoulson I: Effects of tyramine administration in Parkinsons disease
patients treated with selective MAO-B inhibitor rasagiline. Mov Disord
2006, 21:17161721.
92. Conlay LA, Maher TJ, Wurtman RJ: Tyrosines pressor effect in hypotensive
rats is not mediated by tyramine. Life Sci 1984, 35:12071212.
93. Edwards DJ: Possible role of octopamine and tyramine in the antihypertensive
and antidepressant effects of tyrosine. Life Sci 1982, 30:14271434.
94. McDaniel MA, Maier SF, Einstein GO: Brain-specificnutrients: a memory
cure? Nutrition 2003, 19:957975.
95. Polich J, Gloria R: Cognitive effects of a Ginkgo biloba/vinpocetine
compound in normal adults: systematic assessment of perception,
attention and memory. Hum Psychopharmacol 2001, 16:409416.
96. Bahrke MS, Morgan WP, Stegner A: Is ginseng an ergogenic aid? Int J Sport
Nutr Exerc Metab 2009, 19:298322.
97. Engels HJ, Fahlman MM, Wirth JC: Effects of ginseng on secretory IgA,
performance, and recovery from interval exercise. Med Sci Sports Exerc
2003, 35:690696.
98. Goulet ED, Dionne IJ: Assessment of the effects of eleutherococcus senticosus
on endurance performance. Int J Sport Nutr Exerc Metab 2005, 15:7583.
99. Hsu CC, Ho MC, Lin LC, Su B, Hsu MC: American ginseng supplementation
attenuates creatine kinase level induced by submaximal exercise in
human beings. World J Gastroenterol 2005, 11:53275331.
100. Hwang HJ, Kwak YS, Yoon GA, Kang MH, Park JH, Lee BK, Kim SJ, Um SY,
Kim YM: Combined effects of swim training and ginseng
supplementation on exercise performance time, ROS, lymphocyte
proliferation, and DNA damage following exhaustive exercise stress.
Int J Vitam Nutr Res 2007, 77:289296.
101. Kulaputana O, Thanakomsirichot S, Anomasiri W: Ginseng supplementation
does not change lactate threshold and physical performances in
physically active Thai men. J Med Assoc Thai 2007, 90:11721179.
102. Liang MT, Podolka TD, Chuang WJ: Panax notoginseng supplementation
enhances physical performance during endurance exercise.
J Strength Cond Res 2005, 19:108114.
103. Reay JL, Scholey AB, Milne A, Fenwick J, Kennedy DO: Panax ginseng has
no effect on indices of glucose regulation following acute or chronic
ingestion in healthy volunteers. Br J Nutr 2009, 101:16731678.
104. Engels HJ, Kolokouri I, Cieslak TJ 2nd, Wirth JC: Effects of ginseng supplementation
on supramaximal exercise performance and short-term recovery. JStrength
Cond Res 2001, 15:290295.
105. Eschbach LF, Webster MJ, Boyd JC, McArthur PD, Evetovich TK: The effect
of siberian ginseng (Eleutherococcus senticosus) on substrate utilization
and performance. Int J Sport Nutr Exerc Metab 2000, 10:444451.
106. Ferrando A, Vila L, Voces JA, Cabral AC, Alvarez AI, Prieto JG: Effects of
ginseng extract on various haematological parameters during aerobic
exercise in the rat. Planta Med 1999, 65:288290.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 13 of 16
http://www.jissn.com/content/10/1/1
107. Ferrando A, Vila L, Voces JA, Cabral AC, Alvarez AI, Prieto JG: Effects of a
standardized Panax ginseng extract on the skeletal muscle of the rat: a
comparative study in animals at rest and under exercise. Planta Med
1999, 65:239244.
108. Ziemba AW, Chmura J, Kaciuba-Uscilko H, Nazar K, Wisnik P, Gawronski W:
Ginseng treatment improves psychomotor performance at rest and
during graded exercise in young athletes. Int J Sport Nutr 1999,
9:371377.
109. Allen JD, McLung J, Nelson AG, Welsch M: Ginseng supplementation does
not enhance healthy young adultspeak aerobic exercise performance.
J Am Coll Nutr 1998, 17:462466.
110. Engels HJ, Wirth JC: No ergogenic effects of ginseng (Panax ginseng C.A.
Meyer) during graded maximal aerobic exercise. J Am Diet Assoc 1997,
97:11101115.
111. Pieralisi G, Ripari P, Vecchiet L: Effects of a standardized ginseng extract
combined with dimethylaminoethanol bitartrate, vitamins, minerals, and
trace elements on physical performance during exercise. Clin Ther 1991,
13:373382.
112. Karlic H, Lohninger A: Supplementation of L-carnitine in athletes: does it
make sense? Nutrition 2004, 20:709715.
113. Pauly DF, Pepine CJ: D-Ribose as a supplement for cardiac energy metabolism.
J Cardiovasc Pharmacol Ther 2000, 5:249258.
114. Kerksick C, Rasmussen C, Bowden R, Leutholtz B, Harvey T, Earnest C,
Greenwood M, Almada A, Kreider R: Effects of ribose supplementation
prior to and during intense exercise on anaerobic capacity and
metabolic markers. Int J Sport Nutr Exerc Metab 2005, 15:653664.
115. Kreider RB, Melton C, Greenwood M, Rasmussen C, Lundberg J, Earnest C,
Almada A: Effects of oral D-ribose supplementation on anaerobic
capacity and selected metabolic markers in healthy males. Int J Sport
Nutr Exerc Metab 2003, 13:7686.
116. Berardi JM, Ziegenfuss TN: Effects of ribose supplementation on repeated
sprint performance in men. J Strength Cond Res 2003, 17:4752.
117. Dunne L, Worley S, Macknin M: Ribose versus dextrose supplementation,
association with rowing performance: a double-blind study. Clin J Sport
Med 2006, 16:6871.
118. Eijnde BO, Van Leemputte M, Brouns F, Van Der Vusse GJ, Labarque V,
Ramaekers M, Van Schuylenberg R, Verbessem P, Wijnen H, Hespel P: No
effects of oral ribose supplementation on repeated maximal exercise
and de novo ATP resynthesis. J Appl Physiol 2001, 91:22752281.
119. Hellsten Y, Skadhauge L, Bangsbo J: Effect of ribose supplementation on
resynthesis of adenine nucleotides after intense intermittent training in
humans. Am J Physiol Regul Integr Comp Physiol 2004, 286:R182188.
120. Harris RC, Sale C: Beta-alanine supplementation in high-intensity exercise.
Med Sport Sci 2013, 59:117.
121. Hoffman JR, Emerson NS, Stout JR: beta-Alanine supplementation. Curr Sports
Med Rep 2012, 11:189195.
122. Harris RC, Wise JA, Price KA, Kim HJ, Kim CK, Sale C: Determinants of
muscle carnosine content. Amino Acids 2012, 43:512.
123. Culbertson JY, Kreider RB, Greenwood M, Cooke M: Effects of beta-alanine
on muscle carnosine and exercise performance: a review of the current
literature. Nutrients 2010, 2:7598.
124. Hobson RM, Saunders B, Ball G, Harris RC, Sale C: Effects of beta-alanine
supplementation on exercise performance: a meta-analysis. Amino Acids
2012, 43:2537.
125. Smith-Ryan AE, Fukuda DH, Stout JR, Kendall KL: High-velocity intermittent
running: effects of beta-alanine supplementation. J Strength Cond Res
2012, 26:27982805.
126. Saunders B, Sunderland C, Harris RC, Sale C: beta-alanine supplementation
improves YoYo intermittent recovery test performance. J Int Soc Sports
Nutr 2012, 9:39.
127. Jagim AR, Wright GA, Brice AG, Doberstein ST: Effects of beta-alanine
supplementation on sprint endurance. J Strength Cond Res 2012.
128. Sale C, Saunders B, Hudson S, Wise JA, Harris RC, Sunderland CD: Effect of
beta-alanine plus sodium bicarbonate on high-intensity cycling capacity.
Med Sci Sports Exerc 2011, 43:19721978.
129. Kern BD, Robinson TL: Effects of beta-alanine supplementation on
performance and body composition in collegiate wrestlers and football
players. J Strength Cond Res 2011, 25:18041815.
130. Walter AA, Smith AE, Kendall KL, Stout JR, Cramer JT: Six weeks of high-intensity
interval training with and without beta-alanine supplementation for improving
cardiovascular fitness in women. J Strength Cond Res 2010, 24:11991207.
131. Sweeney KM, Wright GA, Glenn Brice A, Doberstein ST: The effect of
beta-alanine supplementation on power performance during repeated
sprint activity. J Strength Cond Res 2010, 24:7987.
132. Sale C, Saunders B, Harris RC: Effect of beta-alanine supplementation on
muscle carnosine concentrations and exercise performance. Amino Acids
2010, 39:321333.
133. Van Thienen R, Van Proeyen K, Vanden Eynde B, Puype J, Lefere T, Hespel P:
Beta-alanine improves sprint performance in endurance cycling. Med Sci
Sports Exerc 2009, 41:898903.
134. Smith AE, Moon JR, Kendall KL, Graef JL, Lockwood CM, Walter AA, Beck TW,
Cramer JT, Stout JR: The effects of beta-alanine supplementation and
high-intensity interval training on neuromuscular fatigue and muscle
function. Eur J Appl Physiol 2009, 105:357363.
135. Kendrick IP, Kim HJ, Harris RC, Kim CK, Dang VH, Lam TQ, Bui TT, Wise JA:
The effect of 4 weeks beta-alanine supplementation and isokinetic
training on carnosine concentrations in type I and II human skeletal
muscle fibres. Eur J Appl Physiol 2009, 106:131138.
136. Stout JR, Graves BS, Smith AE, Hartman MJ, Cramer JT, Beck TW, Harris RC:
The effect of beta-alanine supplementation on neuromuscular fatigue in
elderly (55-92 Years): a double-blind randomized study. J Int Soc Sports
Nutr 2008, 5:21.
137. Hoffman JR, Ratamess NA, Faigenbaum AD, Ross R, Kang J, Stout JR,
Wise JA: Short-duration beta-alanine supplementation increases training
volume and reduces subjective feelings of fatigue in college football
players. Nutr Res 2008, 28:3135.
138. Zoeller RF, Stout JR, OKroy JA, Torok DJ, Mielke M: Effects of 28 days of
beta-alanine and creatine monohydrate supplementation on aerobic
power, ventilatory and lactate thresholds, and time to exhaustion.
Amino Acids 2007, 33:505510.
139. Einat H, Belmaker RH: The effects of inositol treatment in animal models
of psychiatric disorders. J Affect Disord 2001, 62:113121.
140. Sureda A, Pons A: Arginine and citrulline supplementation in sports and
exercise: ergogenic nutrients? Med Sport Sci 2013, 59:1828.
141. Bescos R, Sureda A, Tur JA, Pons A: The effect of nitric-oxide-related
supplements on human performance. Sports Med 2012, 42:99117.
142. Bendahan D, Mattei JP, Ghattas B, Confort-Gouny S, Le Guern ME, Cozzone
PJ: Citrulline/malate promotes aerobic energy production in human
exercising muscle. Br J Sports Med 2002, 36:282289.
143. Figueroa A, Trivino JA, Sanchez-Gonzalez MA, Vicil F: Oral L-citrulline
supplementation attenuates blood pressure response to cold pressor
test in young men. Am J Hypertens 2010, 23:1216.
144. Hickner RC, Tanner CJ, Evans CA, Clark PD, Haddock A, Fortune C, Geddis H,
Waugh W, McCammon M: L-citrulline reduces time to exhaustion and insulin
response to a graded exercise test. Med Sci Sports Exerc 2006, 38:660666.
145. Meneguello MO, Mendonca JR, Lancha AH Jr, Costa Rosa LF: Effect of
arginine, ornithine and citrulline supplementation upon performance
and metabolism of trained rats. Cell Biochem Funct 2003, 21:8591.
146. Nagaya N, Uematsu M, Oya H, Sato N, Sakamaki F, Kyotani S, Ueno K, Nakanishi
N, Yamagishi M, Miyatake K: Short-term oral administration of L-arginine
improves hemodynamics and exercise capacity in patients with
precapillary pulmonary hypertension. Am J Respir Crit Care Med 2001,
163:887891.
147. Perez-Guisado J, Jakeman PM: Citrulline malate enhances athletic
anaerobic performance and relieves muscle soreness. J Strength Cond Res
2010, 24:12151222.
148. Sureda A, Cordova A, Ferrer MD, Perez G, Tur JA, Pons A: L-citrulline-malate
influence over branched chain amino acid utilization during exercise.
Eur J Appl Physiol 2010, 110:341351.
149. Takeda K, Machida M, Kohara A, Omi N, Takemasa T: Effects of citrulline
supplementation on fatigue and exercise performance in mice. J Nutr Sci
Vitaminol (Tokyo) 2011, 57:246250.
150. Kressler J, Millard-Stafford M, Warren GL: Quercetin and endurance
exercise capacity: a systematic review and meta-analysis. Med Sci Sports
Exerc 2011, 43:23962404.
151. Wu J, Gao W, Wei J, Yang J, Pu L, Guo C: Quercetin alters energy
metabolism in swimming mice. Appl Physiol Nutr Metab 2012, 37:912922.
152. Sharp MA, Hendrickson NR, Staab JS, McClung HL, Nindl BC, Michniak-Kohn
BB: Effects of short-term quercetin supplementation on soldier
performance. J Strength Cond Res 2012, 26(Suppl 2):S5360.
153. OFallon KS, Kaushik D, Michniak-Kohn B, Dunne CP, Zambraski EJ, Clarkson
PM: Quercetin does not attenuate changes in markers of muscle
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 14 of 16
http://www.jissn.com/content/10/1/1
function or inflammation after eccentric exercise. Int J Sport Nutr Exerc
Metab 2012, .
154. Konrad M, Nieman DC, Henson DA, Kennerly KM, Jin F, Wallner-Liebmann
SJ: The acute effect of ingesting a quercetin-based supplement on
exercise-induced inflammation and immune changes in runners.
Int J Sport Nutr Exerc Metab 2011, 21:338346.
155. Abbey EL, Rankin JW: Effect of quercetin supplementation on repeated-
sprint performance, xanthine oxidase activity, and inflammation. Int J
Sport Nutr Exerc Metab 2011, 21:9196.
156. Nieman DC, Williams AS, Shanely RA, Jin F, McAnulty SR, Triplett NT, Austin
MD, Henson DA: Quercetins influence on exercise performance and
muscle mitochondrial biogenesis. Med Sci Sports Exerc 2010, 42:338345.
157. Ganio MS, Armstrong LE, Johnson EC, Klau JF, Ballard KD, Michniak-Kohn B,
Kaushik D, Maresh CM: Effect of quercetin supplementation on maximal
oxygen uptake in men and women. J Sports Sci 2010, 28:201208.
158. Bigelman KA, Fan EH, Chapman DP, Freese EC, Trilk JL, Cureton KJ: Effects
of six weeks of quercetin supplementation on physical performance in
ROTC cadets. Mil Med 2010, 175:791798.
159. Utter AC, Nieman DC, Kang J, Dumke CL, Quindry JC, McAnulty SR,
McAnulty LS: Quercetin does not affect rating of perceived exertion in
athletes during the Western States endurance run. Res Sports Med 2009,
17:7183.
160. Dumke CL, Nieman DC, Utter AC, Rigby MD, Quindry JC, Triplett NT,
McAnulty SR, McAnulty LS: Quercetins effect on cycling efficiency and
substrate utilization. Appl Physiol Nutr Metab 2009, 34:9931000.
161. Davis JM, Murphy EA, Carmichael MD, Davis B: Quercetin increases brain
and muscle mitochondrial biogenesis and exercise tolerance.
Am J Physiol Regul Integr Comp Physiol 2009, 296:R10711077.
162. Cureton KJ, Tomporowski PD, Singhal A, Pasley JD, Bigelman KA,
Lambourne K, Trilk JL, McCully KK, Arnaud MJ, Zhao Q: Dietary quercetin
supplementation is not ergogenic in untrained men. J Appl Physiol 2009,
107:10951104.
163. Quindry JC, McAnulty SR, Hudson MB, Hosick P, Dumke C, McAnulty LS,
Henson D, Morrow JD, Nieman D: Oral quercetin supplementation and
blood oxidative capacity in response to ultramarathon competition. Int J
Sport Nutr Exerc Metab 2008, 18:601616.
164. Henson D, Nieman D, Davis JM, Dumke C, Gross S, Murphy A, Carmichael
M, Jenkins DP, Quindry J, McAnulty S, et al:Post-160-km race illness
rates and decreases in granulocyte respiratory burst and salivary IgA
output are not countered by quercetin ingestion. Int J Sports Med 2008,
29:856863.
165. Nieman DC, Henson DA, Gross SJ, Jenkins DP, Davis JM, Murphy EA,
Carmichael MD, Dumke CL, Utter AC, McAnulty SR, et al:Quercetin reduces
illness but not immune perturbations after intensive exercise.
Med Sci Sports Exerc 2007, 39:15611569.
166. Nieman DC, Henson DA, Davis JM, Angela Murphy E, Jenkins DP, Gross SJ,
Carmichael MD, Quindry JC, Dumke CL, Utter AC, et al:Quercetins
influence on exercise-induced changes in plasma cytokines and muscle
and leukocyte cytokine mRNA. J Appl Physiol 2007, 103:17281735.
167. Campbell B, Downing J, Kilpatrick M, La Bounty P, Elkins A, Williams S,
dos Santos MG: The effects of a commercially available energy drink
on resistance training and performance. Med Sci Sports Exerc 2010,
42:S315.
168. Forbes SC, Candow DG, Little JP, Magnus C, Chilibeck PD: Effect of Red Bull
energy drink on repeated Wingate cycle performance and bench-press
muscle endurance. Int J Sport Nutr Exerc Metab 2007, 17:433444.
169. Hoffman JR, Kang J, Ratamess NA, Hoffman MW, Tranchina CP,
Faigenbaum AD: Examination of a pre-exercise, high energy supplement
on exercise performance. J Int Soc Sports Nutr 2009, 6:2.
170. Candow DG, Kleisinger AK, Grenier S, Dorsch KD: Effect of sugar-free Red
Bull energy drink on high-intensity run time-to-exhaustion in young
adults. J Strength Cond Res 2009, 23:12711275.
171. Cureton KJ, Warren GL, Millard-Stafford ML, Wingo JE, Trilk J, Buyckx M:
Caffeinated sports drink: ergogenic effects and possible mechanisms.
Int J Sport Nutr Exerc Metab 2007, 17:3555.
172. Alford C, Cox H, Wescott R: The effects of red bull energy drink on human
performance and mood. Amino Acids 2001, 21:139150.
173. Campbell B, Kilpatrick M, Wilborn C, La Bounty P, Parker B, Gomez B,
Elkins A, Williams S, Dos Santos JA: A commercially available energy drink
does not improve peak power on multiple 20-second Wingate tests.
J Int Soc Sports Nutr 2010, 7:P10.
174. Gonzalez AM, Walsh AL, Ratamess NA, Kang J, Hoffman JR: Effect of a
pre-workout energy supplement on acute multi-joint resistance exercise.
J Sports Sci Med 2011, 10:261266.
175. Astorino TA, Matera AJ, Basinger J, Evans M, Schurman T, Marquez R:
Effects of red bull energy drink on repeated sprint performance in
women athletes. Amino Acids 2012, 42:18031808.
176. Haff GG, Koch AJ, Potteiger JA, Kuphal KE, Magee LM, Green SB, Jakicic JJ:
Carbohydrate supplementation attenuates muscle glycogen loss during
acute bouts of resistance exercise. Int J Sport Nutr Exerc Metab 2000,
10:326339.
177. Kulik JR, Touchberry CD, Kawamori N, Blumert PA, Crum AJ, Haff GG:
Supplemental carbohydrate ingestion does not improve performance of
high-intensity resistance exercise. J Strength Cond Res 2008, 22:11011107.
178. Lambert CP, Flynn MG, Boone JB Jr, Michaud TJ, Rodriguez-Zayas J:
Effects of carbohydrate feeding on multiple bout resistance exercised.
J Appl Sport Sci Res 1991, 5:192197.
179. Walsh AL, Gonzalez AM, Ratamess NA, Kang J, Hoffman JR: Improved time
to exhaustion following ingestion of the energy drink Amino Impact.
J Int Soc Sports Nutr 2010, 7:14.
180. Currell K, Jeukendrup AE: Validity, reliability and sensitivity of measures of
sporting performance. Sports Med 2008, 38:297316.
181. Laursen PB, Francis GT, Abbiss CR, Newton MJ, Nosaka K: Reliability of
time-to-exhaustion versus time-trial running tests in runners.
Med Sci Sports Exerc 2007, 39:13741379.
182. Scholey AB, Kennedy DO: Cognitive and physiological effects of an
energy drink: an evaluation of the whole drink and of glucose, caffeine
and herbal flavouring fractions. Psychopharmacology (Berl) 2004, 176:320330.
183. Smit HJ, Cotton JR, Hughes SC, Rogers PJ: Mood and cognitive
performance effects of energydrink constituents: caffeine, glucose and
carbonation. Nutr Neurosci 2004, 7:127139.
184. Rao A, Hu H, Nobre AC: The effects of combined caffeine and glucose
drinks on attention in the human brain. Nutr Neurosci 2005, 8:141153.
185. Howard MA, Marczinski CA: Acute effects of a glucose energy drink on
behavioral control. Exp Clin Psychopharmacol 2010, 18:553561.
186. Pettitt RW, Niemeyer JD, Sexton PJ, Lipetzky A, Murray SR: Do the
non-caffeine ingredients of energy drinks affect metabolic responses to
heavy exercise? J Strength Cond Res 2012, [Epub ahead of print].
187. Bloomer RJ, Fisher-Wellman KH, Hammond KG, Schilling BK, Weber AA, Cole BJ:
Dietary supplement increases plasma norepinephrine, lipolysis, and
metabolic rate in resistance trained men. J Int Soc Sports Nutr 2009, 6:4.
188. Dulloo AG, Geissler CA, Horton T, Collins A, Miller DS: Normal caffeine
consumption: influence on thermogenesis and daily energy expenditure
in lean and postobese human volunteers. Am J Clin Nutr 1989, 49:4450.
189. Jitomir J, Nassar E, Culbertson J, Moreillon J, Buford T, Hudson G, Cooke M,
Kreider R, Willoughby DS: The acute effects of the thermogenic
supplement Meltdown on energy expenditure, fat oxidation, and
hemodynamic responses in young, healthy males. J Int Soc Sports Nutr
2008, 5:23.
190. Mendel RW, Hofheins JE: Metabolic responses to the acute ingestion of
two commercially available carbonated beverages: a pilot study. J Int Soc
Sports Nutr 2007, 4:7.
191. Rudelle S, Ferruzzi MG, Cristiani I, Moulin J, Mace K, Acheson KJ, Tappy L:
Effect of a thermogenic beverage on 24-hour energy metabolism in
humans. Obesity (Silver Spring) 2007, 15:349355.
192. Taylor LW, Wilborn CD, Harvey T, Wismann J, Willoughby DS: Acute effects
of ingesting Java Fittrade mark energy extreme functional coffee on
resting energy expenditure and hemodynamic responses in male and
female coffee drinkers. J Int Soc Sports Nutr 2007, 4:10.
193. Wilborn C, Taylor L, Poole C, Bushey B, Williams L, Foster C, Campbell B:
Effects of ingesting a commercial thermogenic product on
hemodynamic function and energy expenditure at rest in males and
females. Appl Physiol Nutr Metab 2009, 34:10731078.
194. Roberts MD, Dalbo VJ, Hassell SE, Stout JR, Kerksick CM: Efficacy and safety
of a popular thermogenic drink after 28 days of ingestion.
J Int Soc Sports Nutr 2008, 5:19.
195. Dalbo VJ, Roberts MD, Stout JR, Kerksick CM: Acute effects of ingesting a
commercial thermogenic drink on changes in energy expenditure and
markers of lipolysis. J Int Soc Sports Nutr 2008, 5:6.
196. Dalbo VJ, Roberts MD, Stout JR, Kerksick CM: Effect of gender on the
metabolic impact of a commercially available thermogenic drink.
J Strength Cond Res 2010, 24:16331642.
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 15 of 16
http://www.jissn.com/content/10/1/1
197. Rashti SL, Ratamess NA, Kang J, Faigenbaum AD, Chilakos A, Hoffman JR:
Thermogenic effect of meltdown RTD energy drink in young healthy
women: a double blind, cross-over design study. Lipids Health Dis 2009,
8:57.
198. Bloomer RJ, Canale RE, Blankenship MM, Hammond KG, Fisher-Wellman KH,
Schilling BK: Effect of the dietary supplement Meltdown on
catecholamine secretion, markers of lipolysis, and metabolic rate in men
and women: a randomized, placebo controlled, cross-over study.
Lipids Health Dis 2009, 8:32.
199. Stout J, Moon J, Tobkin S, Lockwood C, Smith A, Graef J, Kendall K, Beck T,
Cramer J: Pre-workout consumption of Celsius(R) enhances the benefits
of chronic exercise on body composition and cardiorespiratory fitness.
J Int Soc Sports Nutr 2008, 5:P8.
200. Higgins JP, Tuttle TD, Higgins CL: Energy beverages: content and safety.
Mayo Clin Proc 2010, 85:10331041.
201. Sepkowitz KA: Energy drinks and caffeine-related adverse effects.
JAMA 2012, :12 [Epub ahead of print].
202. Torpy JM, Livingston EH: Energy drinks. JAMA 2012, :11 [Epub ahead of
print].
203. Howland JRDJ: Risks of energy drinks mixed with alcohol. JAMA 2012, :12
[Epub ahead of print].
204. Clauson KA, Shields KM, McQueen CE, Persad N: Safety issues associated
with commercially available energy drinks. J Am Pharm Assoc (2003) 2008,
48:e5563. quiz e64-57.
205. Duchan E, Patel ND, Feucht C: Energy drinks: a review of use and safety
for athletes. Phys Sportsmed 2010, 38:171179.
206. Lockwood CM, Moon JR, Smith AE, Tobkin SE, Kendall KL, Graef JL,
Cramer JT, Stout JR: Low-calorie energy drink improves physiological
response to exercise in previously sedentary men: a placebo-controlled
efficacy and safety study. J Strength Cond Res 2010, 24:22272238.
207. Pennington N, Johnson M, Delaney E, Blankenship MB: Energy drinks:
a new health hazard for adolescents. J Sch Nurs 2010, 26:352359.
208. Weiss EP, Arif H, Villareal DT, Marzetti E, Holloszy JO: Endothelial function
after high-sugar-food ingestion improves with endurance exercise
performed on the previous day. Am J Clin Nutr 2008, 88:5157.
209. Petit A, Levy F, Lejoyeux M, Reynaud M, Karila L: Energy drinks:
an unknown risk. Rev Prat 2012, 62:673678.
210. Why isnt the amount of caffeine a product contains required of a food label?.
http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194317.htm.
211. Health Canadas proposed approach to managing caffeinated energy drinks. http://
www.hc-sc.gc.ca/fn-an/legislation/pol/energy-drinks-boissons-energisantes-
eng.php.
212. McCusker RR, Goldberger BA, Cone EJ: Caffeine content of specialty
coffees. J Anal Toxicol 2003, 27:520522.
213. Jin KN, Chun EJ, Lee CH, Kim JA, Lee MS, Choi SI: Subclinical coronary
atherosclerosis in young adults: prevalence, characteristics, predictors
with coronary computed tomography angiography. Int J Cardiovasc
Imaging 2012, [Epub ahead of print].
214. Thiene G, Carturan E, Corrado D, Basso C: Prevention of sudden cardiac
death in the young and in athletes: dream or reality? Cardiovasc Pathol
2010, 19:207217.
215. Radojevic N, Bjelogrlic B, Aleksic V, Rancic N, Samardzic M, Petkovic S,
Savic S: Forensic aspects of water intoxication: four case reports and
review of relevant literature. Forensic Sci Int 2012, 220:15.
216. Holmgren P, Norden-Pettersson L, Ahlner J: Caffeine fatalitiesfour case
reports. Forensic Sci Int 2004, 139:7173.
217. Kerrigan S, Lindsey T: Fatal caffeine overdose: two case reports.
Forensic Sci Int 2005, 153:6769.
218. Rudolph T, Knudsen K: A case of fatal caffeine poisoning. Acta Anaesthesiol
Scand 2010, 54:521523.
219. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M:
Effects of caffeine on human health. Food Addit Contam 2003, 20:130.
220. Higdon JV, Frei B: Coffee and health: a review of recent human research.
Crit Rev Food Sci Nutr 2006, 46:101123.
221. Usman A, Jawaid A: Hypertension in a young boy: an energy drink effect.
BMC Res Notes 2012, 5:591.
222. Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willoughby SR:
Detrimental effects of energy drink consumption on platelet and
endothelial function. Am J Med 2010, 123:184187.
223. Steinke L, Lanfear DE, Dhanapal V, Kalus JS: Effect of energy drink
consumption on hemodynamic and electrocardiographic parameters in
healthy young adults. Ann Pharmacother 2009, 43:596602.
224. Adverse event reporting for dietary supplements: an inadequate safety valve.
https://oig.hhs.gov/oei/reports/oei-01-00-00180.pdf.
doi:10.1186/1550-2783-10-1
Cite this article as: Campbell et al.:International Society of Sports
Nutrition position stand: energy drinks. Journal of the International Society
of Sports Nutrition 2013 10:1.
Submit your next manuscript to BioMed Central
and take full advantage of:
Convenient online submission
Thorough peer review
No space constraints or color figure charges
Immediate publication on acceptance
Inclusion in PubMed, CAS, Scopus and Google Scholar
Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit
Campbell et al. Journal of the International Society of Sports Nutrition 2013, 10:1 Page 16 of 16
http://www.jissn.com/content/10/1/1
... Energy drinks refer to a category of drinks that include variable amounts of caffeine, the most common ingredient, as well as various other ingredients that may include taurine, guarana, ginkgo biloba, carnitine, panax ginseng, green tea, carbohydrates, glucuronolactone, vitamins and minerals [1][2][3]. There is a growing problem regarding energy drink consumption, and serious adverse effects and toxicity have been documented, together with increasing numbers of emergency department visits and hospitalizations [3][4][5][6][7]. ...
... Energy drinks refer to a category of drinks that include variable amounts of caffeine, the most common ingredient, as well as various other ingredients that may include taurine, guarana, ginkgo biloba, carnitine, panax ginseng, green tea, carbohydrates, glucuronolactone, vitamins and minerals [1][2][3]. There is a growing problem regarding energy drink consumption, and serious adverse effects and toxicity have been documented, together with increasing numbers of emergency department visits and hospitalizations [3][4][5][6][7]. Several adverse cardiovascular events after consuming energy drinks have been reported in the literature due to arrhythmic events or myocardial infarction [8], but none describing direct myocyte toxicity. ...
... Energy drinks are widely disseminated, with higher consumption being reported in adolescents and young adults [1,3,6,7,10]. Their main component is caffeine and some reports advocate that it is, together with carbohydrates, the main responsible for the side effects of energy drinks [3,5,6]. The relative importance of the various ingredients is not fully understood, being di cult to access cause and effect and assign it to one speci c ingredient. ...
Preprint
Full-text available
There is a growing problem regarding energy drink consumption and several adverse cardiovascular events after consuming energy drinks have been reported in the literature, due to arrhythmic events or myocardial infarction, but none describing direct myocyte toxicity. We perform a brief review of energy drink associated cardiovascular effects already described in the literature and present the first ever described case associating energy drink consumption to myocarditis.
... Caffeine is one of the most common naturally occurring nootropic nutrients in beverages that help maintain alertness, mental function, and exercise performance [7][8][9]. According to the International Society of Sports Nutrition, ingesting 3-6 mg/kg of caffeine about 60 minutes before exercise can improve cognition, attention, vigilance, and exercise performance [8,10]. However, the effects of ingesting caffeine before exercise vary depending on the type, amount, and length of exercise. ...
... Athletes often consume caffeinated beverages to increase energy, maintain alertness and/or provide cognitive or ergogenic benefits [1,4,9,10,60,61]. While caffeine's pharmacokinetics and ergogenic value have been well documented [7,8,15,60,[62][63][64], less is known about paraxanthine. ...
Article
Full-text available
Rationale Intense exercise promotes fatigue and can impair cognitive function, particularly toward the end of competition when decision-making is often critical for success. For this reason, athletes often ingest caffeinated energy drinks prior to or during exercise to help them maintain focus, reaction time, and cognitive function during competition. However, caffeine habituation and genetic sensitivity to caffeine (CA) limit efficacy. Paraxanthine (PX) is a metabolite of caffeine reported to possess nootropic properties. This study examined whether ingestion of PX with and without CA affects pre- or post-exercise cognitive function. Methods 12 trained runners were randomly assigned to consume in a double-blind, randomized, and crossover manner 400 mg of a placebo (PL); 200 mg of PL + 200 mg of CA; 200 mg of PL + 200 mg of PX (ENFINITY®, Ingenious Ingredients); or 200 mg PX + 200 mg of CA (PX+CA) with a 7–14-day washout between treatments. Participants donated fasting blood samples and completed pre-supplementation (PRE) side effects questionnaires, the Berg-Wisconsin Card Sorting Test (BCST), and the Psychomotor Vigilance Task Test (PVTT). Participants then ingested the assigned treatment and rested for 60 minutes, repeated tests (PRE-EX), performed a 10-km run on a treadmill at a competition pace, and then repeated tests (POST-EX). Data were analyzed using General Linear Model (GLM) univariate analyses with repeated measures and percent changes from baseline with 95% confidence intervals. Results BCST correct responses in the PX treatment increased from PRE-EX to POST-EX (6.8% [1.5, 12.1], p = 0.012). The error rate in the PL (23.5 [−2.8, 49.8] %, p = 0.078) and CA treatment (31.5 [5.2, 57.8] %, p = 0.02) increased from PRE-EX values with POST-EX errors tending to be lower with PX treatment compared to CA (−35.7 [−72.9, 1.4] %, p = 0.059). POST-EX perseverative errors with PAR rules were significantly lower with PX treatment than with CA (−26.9 [−50.5, −3.4] %, p = 0.026). Vigilance analysis revealed a significant interaction effect in Trial #2 mean reaction time values (p = 0.049, ηp2 = 0.134, moderate to large effect) with POST-EX reaction times tending to be faster with PX and CA treatment. POST-EX mean reaction time of all trials with PX treatment was significantly faster than PL (−23.2 [−43.4, −2.4] %, p = 0.029) and PX+CA (−29.6 [−50.3, −8.80] %, p = 0.006) treatments. There was no evidence that PX ingestion adversely affected ratings of side effects associated with stimulant intake or clinical blood markers. Conclusions Results provide some evidence that pre-exercise PX ingestion improves prefrontal cortex function, attenuates attentional decline, mitigates cognitive fatigue, and improves reaction time and vigilance. Adding CA to PX did not provide additional benefits. Therefore, PX ingestion may serve as a nootropic alternative to CA.
... Therefore, strategies that minimize or delay the deleterious fatigue effects shall contribute to performance increases in endurance sports. Some studies have investigated different acute strategies for improving sports performance [4,5]. A current strategy to delay fatigue effects that were used in recent studies is the application of photobiomodulation therapy (PBMT) over the skeletal muscles prior to exercise since PBMT was able to increase performance during different exercises [6], including running [7][8][9] and cycling [10]. ...
Article
Full-text available
The goal of this study was to investigate the effects of photobiomodulation therapy (PBMT) on performance, oxygen uptake (VO2) kinetics, and lower limb muscle oxygenation during three successive time-to-exhaustions (TTEs) in cyclists. This was a double-blind, randomized, crossover, placebo-controlled trial study. Sixteen cyclists (~23 years) with a cycling training volume of ~460 km/week volunteered for this study. In the first session, cyclists performed a maximal incremental test to determine maximal oxygen uptake and maximal power output (POMAX). In the following sessions, cyclists performed three consecutive TTEs at POMAX. Before each test, PBMT (135 J/thigh) or a placebo (PLA) was applied to both thighs. VO2 amplitude, O2 deficit, time delay, oxyhemoglobin (O2Hb), deoxyhemoglobin (HHb), and total hemoglobin (tHb) were measured during tests on the right vastus lateralis. The PBMT applied before three successive TTE increased performance of the first and second TTE (~10–12%) tests, speed of VO2 and HHb kinetics during the first test, and increased peripheral muscle oxygenation (increase in HHb and tHb) in the first and second exhaustion tests. However, the PBMT effects were attenuated in the third TTE, as performance and all the other outcomes were similar to the ones from the PLA intervention. In summary, PBMT application increased the first and second successive TTEs, speed of VO2, and muscle oxygenation.
... EDs are the most popular commercially available beverage consumed specially by athletes and adolescents (Erdmann et al. 2021) for their reported ergogenic properties which present enhanced physical performance and psychological support (Tambalis 2022). EDs mainly contain high amounts of caffeine to arouse concentration and muscular capacity (Campbell et al. 2013). This study was conducted to investigate the threatening effects of chronic consumption of EDs on the stomach in a rat model of pyloric ligation. ...
Article
Full-text available
Nowadays energy drinks (EDs) are widely used among teenagers. One of the most popular EDs in Egypt is Red BullR (RB). The aim of this study was to evaluate the chronic effects of RB on gastric acidity, oxidative stress, and inflammation in pylorus-ligated rats. Thirty-two adult male albino rats were divided into 4 groups; Control animals were given distilled water instead of a beverage. RB was given in doses of 5, 7.5, and 10 ml/kg, p.o., twice daily for 28 days in pylorus-ligated rats. The effects of different doses of RB were investigated on body weight, gastric acidity, and volume and pH of gastric secretions. Biochemical indices of oxidative status including malondialdehyde (MDA), glutathione (GSH), and nitric oxide (NO) were also measured. In addition, interleukin-6 (IL-6), and tumor necrosis factor α (TNF-α) were evaluated. Pretreatment with RB significantly increased body weight, gastric juice volume, acidity, and decreased pH in a dose-dependent manner. Moreover, oral administration of RB resulted in a significant increase in levels of MDA, NO, IL-6, and TNF-α along with decreasing GSH in stomach homogenate. The stomach of rats treated with RB showed sporadic focal records of apoptotic bodies in lining mucosal cells. Moreover; higher records of mucosal/submucosal inflammatory cell infiltrate were observed with more severe submucosal edema. Chronic consumption of RB increased gastric acidity, oxidative stress, and inflammation along with decreasing mucus secretion in rat stomach.
Article
Full-text available
Background: Professional nurses who study part-time are faced with demanding tasks, demanding routine, having to cope with their studies and family commitments. Some nurses try different tactics to cope with their demanding tasks, such as the consumption of energy drinks, to alleviate tiredness and fatigue. Although these energy drinks can alleviate fatigue and boost their energy levels, they have adverse effects to their health such as migraines, insomnia, seizures, arrhythmias and other cardiovascular complications.Aim: To determine the health effects of energy drinks among nurses studying part-time.Setting: Selected university in the Gauteng province, South Africa.Methods: Descriptive, quantitative method that was contextual in nature was used. Self-administered questionnaire was used to collect data from a conveniently sampled population to determine the health effects of the use of energy drinks. Data analysis were done by means of descriptive statistics using the Statistical package for Social Sciences version 26.Results: Findings indicated that nurses studying part-time experience fatigue (n = 86; 49%). To alleviate fatigue (n = 91; 52%), they use energy drinks.Conclusion: Use of energy drinks is prevalent among the nurses because of fatigue caused by studying while working. To reduce the use of energy drinks, the participants need study leave and to be supported by their families and employers.Contribution: The study encourages reduction or prevent the use of energy drinks by nurses who work and study part-time. Participants must use time management as a coping mechanism.
Article
Caffeine is an ergogenic substance that is consumed globally in many forms. The use of buccally absorbable formulations instead of gastrointestinal uptake has become increasingly popular over the years, especially when accelerated absorption with minimal gastrointestinal stress is desired. This study investigated the impact of five different formulations and administration routes of caffeine on the whole blood concentrations of caffeine, paraxanthine, and theobromine: caffeinated capsules, tablets, shots, pouches, and chewing gums. A uniform dose of caffeine (200 mg) was administered to 16 healthy recreational athletes (26.0 ± 2.1 years) using a randomized crossover design. Samples were taken in the form of dried blood spots at 16 different time points in a 2-hr timeframe after drug administration. The samples were analyzed using a validated liquid chromatography–tandem mass spectrometry method. The results for caffeine showed no significant differences in the overall bioavailability (area under the concentration–time curve), maximal concentration, and time to maximum concentration. However, when analyzing the bioavailability of caffeine in the first 5, 10, and 15 min, the liquid caffeine formulation was superior to other administered forms ( p < .05). This indicates that caffeine solubility has a major influence on its absorption rate. In sports, the rate of caffeine absorption must be considered, not only when ingesting anhydrous caffeine, but also when choosing buccal absorption. These findings imply that general guidelines for ergogenic caffeine use should consider the formulation used and, accordingly, the corresponding route of absorption.
Article
Full-text available
Introduction Eurycoma longifolia Jack (EL), profoundly recognised as ‘Tongkat Ali’, is a medicinal herb originating from Southeast Asia. It is commonly used in traditional ‘antiageing’ treatments to address decreased energy, mood, libido and hormonal imbalances. While the benefits of EL have been extensively studied among the male population, less attention has been given to its effects on women. Menopause can impact the overall well-being of middle-aged women and incorporation of herbal supplements can aid them in managing the menopausal symptoms. Methods and analysis This 12-week randomised double-blind, placebo-controlled, parallel-group study aims to evaluate the efficacy of the standardised water extract of EL known as Physta in increasing the quality of life of perimenopausal and postmenopausal women. The study involves 150 women aged 40–55 years who score more than 61 on the Menopause-Specific Quality of Life (MENQOL) assessment. These participants will be randomised into three groups, receiving Physta at either 50 mg or 100 mg or a placebo. The outcomes measures include mood state, quality of life, fatigue, sleep quality, sexual function and pain score assessed using Profile of Mood State, MENQOL, Chalder Fatigue Scale, Pittsburgh Sleep Quality Index, Female Sexual Function Index and the Brief Pain Inventory questionnaires, respectively. The secondary outcome of the study includes full blood analysis, urine analysis, female reproductive hormone profiling, inflammatory and oxidative stress biomarkers analysis. Ethics and dissemination The research protocol of the study was reviewed and approved by the Research Ethics Committee of Universiti Kebangsaan Malaysia (UKM/PPI/111/8/JEP-2021-898). The findings will be disseminated to participants, healthcare professionals and researchers via conference presentations and peer-reviewed publications. Trial registration number ACTRN12622001341718.
Article
Full-text available
To test the efficacy of tyrosine supplementation, as an adjunct to dietary treatment, on neuropsychological test performance in individuals with phenylketonuria. A randomised controlled trial of tyrosine supplementation using a double blind crossover procedure with three four week phases. The Hospital for Sick Children, Toronto. 21 individuals with phenylketonuria (ages 6 to 28 years, mean 11.3). Participants were given 100 mg/kg body weight/d of L-tyrosine or L-alanine (placebo). At baseline, performance on several of the neuropsychological test measures was correlated with tyrosine levels. Dietary supplements of tyrosine increased plasma tyrosine concentrations; however, no change in test performance was found across the tyrosine and placebo phases of the study. Tyrosine supplementation of this type does not appear to alter neuropsychological performance in individuals with phenylketonuria.
Article
Full-text available
BACKGROUND: Endothelial function deteriorates after glucose ingestion. This may be attributed to hyperglycemia-induced oxidative stress. Acute endurance exercise might improve postprandial endothelial function by enhancing glucoregulation and reducing postprandial hyperglycemia. OBJECTIVE: The objective was to determine whether endurance exercise performed 17 h before high-sugar-food ingestion attenuates postprandial impairment in endothelial function. DESIGN: Healthy men and women (n = 13; age: 48 +/- 17 y) were studied on 2 occasions: after > or = 48 h with no exercise and 17 h after a 60-min bout of endurance exercise. During each trial, brachial artery flow mediated dilation (FMD) was used to assess endothelial function before and after the ingestion of a candy bar and soft drink. Glucose, insulin, and thiobarbituric acid-reactive substances (TBARS), a marker of oxidative stress, were measured in blood obtained during each FMD measurement. The insulin sensitivity index was calculated from the glucose and insulin data. RESULTS: FMD decreased significantly after food ingestion in both trials. However, prior exercise shifted the entire FMD curve upward (main treatment effect: P = 0.0002), which resulted in a greater area under the curve for FMD (774 +/- 122%.min) than did no exercise (607 +/- 122%.min) (P = 0.01). Prior exercise shifted the glucose and insulin curves downward (main treatment effects: P = 0.05 and P = 0.0007, respectively) and resulted in a significantly greater insulin sensitivity index (10.8 +/- 0.7) than did no exercise (9.2 +/- 0.7) (P = 0.01). TBARS did not differ significantly between trials. CONCLUSION: Postprandial endothelial function was improved by endurance exercise performed approximately 17 h earlier. This effect was accompanied by exercise-induced improvements in insulin action and reductions in glycemia, but did not correspond with reductions in oxidative stress, as assessed by TBARS.
Article
Full-text available
The use of nutritional ergogenic aids containing Eleutherococcus senticosus (ES), a plant which is also known as ciwujia or Siberian ginseng, is relatively common among endurance athletes. Eleutherococcus senticosus has been suggested to improve cardiorespiratory fitness (CF) and fat metabolism (FAM) and, therefore, endurance performance (EP). This article reviews the studies that evaluated the effects of ES during endurance exercise, three of which suggest that ES substantially improves CF, FAM, and EP. However, each of these reports contains severe methodological flaws, which seriously threaten their internal validity, thereby rendering hazardous the generalization of the results. On the other hand, 5 studies that used rigorous research protocols show no benefit of ES on CF, FAM, and EP It is therefore concluded that ES supplementation (up to 1000 to 1200 mg/d for 1 to 6 wk) offers no advantage during exercise ranging in duration from 6 to 120 min.
Article
Full-text available
Bitter orange (Citrus aurantium) extract is widely used in dietary supplements for weight management and sports performance. Its primary protoalkaloid is p-synephrine. Most studies involving bitter orange extract and p-synephrine have used products with multiple ingredients. The current study assessed the thermogenic effects of p-synephrine alone and in conjunction with the flavonoids naringin and hesperidin in a double-blinded, randomized, placebo-controlled protocol with 10 subjects per treatment group. Resting metabolic rates (RMR), blood pressure, heart rates and a self-reported rating scale were determined at baseline and 75 min after oral ingestion of the test products in V-8 juice. A decrease of 30 kcal occurred in the placebo control relative to baseline. The group receiving p-synephrine (50 mg) alone exhibited a 65 kcal increase in RMR as compared to the placebo group. The consumption of 600 mg naringin with 50 mg p-synephrine resulted in a 129 kcal increase in RMR relative to the placebo group. In the group receiving 100 mg hesperidin in addition to the 50 mg p-synephrine plus 600 mg naringin, the RMR increased by 183 kcal, an increase that was statistically significant with respect to the placebo control (p<0.02). However, consuming 1000 mg hesperidin with 50 mg p-synephrine plus 600 mg naringin resulted in a RMR that was only 79 kcal greater than the placebo group. None of the treatment groups exhibited changes in heart rate or blood pressure relative to the control group, nor there were no differences in self-reported ratings of 10 symptoms between the treatment groups and the control group. This unusual finding of a thermogenic combination of ingredients that elevated metabolic rates without corresponding elevations in blood pressure and heart-rates warrants longer term studies to assess its value as a weight control agent.
Article
We review the experimental evaluations of several widely marketed nonprescription compounds claimed to be memory enhancers and treatments for age-related memory decline. We generally limit our review to double-blind placebo-controlled studies. The compounds examined are phos-phatidylserine (PS), phosphatidylcholine (PC), citicoline, piracetam, vinpocetine, acetyl-L-carnitine (ALC), and antiox-idants (particularly vitamin E). In animals, PS has been shown to attenuate many neuronal effects of aging, and to restore normal memory on a variety of tasks. Preliminary findings with humans, though, are limited. For older adults with probable Alzheimer's disease, a single study failed to demonstrate positive effects of PS on memory performance. For older adults with moderate cognitive impairment, PS has produced consistently modest increases in recall of word lists. Positive effects have not been as consistently reported for other memory tests. There is one report of consistent benefits across a number of memory tests for a subset of normal adults who performed more poorly than their peers at baseline. The choline compounds PC and citicoline are thought to promote synthesis and transmission of neurotransmitters important to memory. PC has not proven effective for improving memory in patients with probable Alzheimer's disease. The issue remains open for older adults without serious degenerative neural disease. Research on citicoline is practically nonexistent, but one study reported a robust improvement in story recall for a small sample of normally aging older adults who scored lower than their peers in baseline testing. Animal studies suggest that piracetam may improve neuronal efficiency, facilitate activity in neurotransmitter systems, and combat the age-related decrease in receptors on the neuronal membrane. However, for patients with probable Alzheimer's disease, as well as for adults with age-associated memory impairment, there is no clear-cut support for a mnemonic benefit of piracetam. Vinpocetine increases blood circulation and metabolism in the brain. Animal studies have shown that vinpocetine can reduce the loss of neurons due to decreased blood flow. In three studies of older adults with memory problems associated with poor brain circulation or dementia-related disease, vinpocetine produced significantly more improvement than a placebo in performance on global cognitive tests reflecting attention, concentration, and memory. Effects on episodic memory per se have been tested minimally, if at all. ALC participates in cellular energy production, a process especially important in neurons, and in removal of toxic accumulation of fatty acids. Animal studies show that ALC reverses the age-related decline in the number of neuron membrane receptors. Studies of patients with probable Alzheimer's disease have reported nominal advantages over a range of memory tests for ALC-treated patients relative to placebo groups. Significant differences have been reported rarely, however. Whether ALC would have mnemonic benefits for aging adults without brain disease is untested as far as we know. Antioxidants help neutralize tissue-damaging free radicals, which become more prevalent as organisms age. It is hypothesized that increasing antioxidant levels in the organism might retard or reverse the damaging effects of free radicals on neurons. Thus far, however, studies have found that vitamin E does not significantly slow down memory decline for Alzheimer's patients and does not produce significant memory benefits among early Parkinson's patients. Neither did a combination of vitamins E and C significantly improve college students' performance on several cognitive tasks. In sum, for most of the “brain-specific” nutrients we review, some mildly suggestive effects have been found in preliminary controlled studies using standard psychometric memory assessments or more general tests designed to reveal cognitive impairment. We suggest that future evaluations of the possible memory benefits of these supplements might fruitfully focus on memory processes rather than on memory tests per se. © 2002, Association for Psychological Science. All rights reserved.
Article
This study tested the acute anti-inflammatory and immune-modulating influence of a quercetin-based supplement consumed by endurance athletes 15 min before an intense 2-hr run. In this randomized, crossover study, 20 runners (11 men, 9 women, age 38.4 ± 2.1 yr) completed two 2-hr treadmill runs at 70% VO2max (3 wk apart). Subjects ingested either 4 quercetin-based chews (Q-chew) or placebo chews (PL) 15 min before the runs. The 4 Q-chews provided 1,000 mg quercetin, 120 mg epigallocatechin 3-gallate, 400 mg isoquercetin, 400 mg each eicosapentaenoic acid and docosahexaenoic acid, 1,000 mg vitamin C, and 40 mg niacinamide. Subjects provided blood samples 30 min before, immediately after, and 1 hr postexercise and were analyzed for plasma quercetin, total blood leukocytes (WBC), C-reactive protein (CRP), 9 cytokines (IL-6, TNFα, GM-CSF, IFNγ, IL-1β, IL-2, IL-8, IL-10, and IL-12p70), granulocyte (GR) and monocyte (MO) phagocytosis (PHAG), and oxidative-burst activity (OBA). Plasma quercetin increased from 80.0 ± 26.0 μg/L to 6,337 ± 414 μg/L immediately postexercise and 4,324 ± 310 μg/L 1 hr postexercise after ingestion of Q-chews, compared with no change in PL (p < .001). Exercise caused significant increases in, CRP, GM-CSF, IL-10, IL-1β, IL-2, IL-6, IL-8, TNFα, GR-PHAG, and MO-PHAG and decreases in GR-OBA and MO-OBA, but no differences in the pattern of change were measured between Q-chew and PL trials. Acute ingestion of Q-chews 15 min before heavy exertion caused a strong increase in plasma quercetin levels but did not counter postexercise inflammation or immune changes relative to placebo.
Article
This study examined whether the prior consumption of coffee (COF) decreased the ergogenic effect of the subsequent ingestion of anhydrous caffeine (CAF). Thirteen subjects performed 6 rides to exhaustion at 80% VO2max 1.5 h after ingesting combinations of COF, decaffeinated coffee (DECOF), CAF, or placebo. The conditions were DECOF + placebo (A), DECOF + CAF (5 mg/kg) (B), COF (1.1 mg/kg caffeine) + CAF (5 mg/kg) (C), COF + CAF (3 mg/kg) (D), COF + CAF (7 mg/kg) (E), and colored water + CAF (5 mg/kg) (F). Times to exhaustion were significantly greater for all trials with CAF versus placebo (trial A). Exercise times (in minutes) were: 21.7 +/- 8.1, 29.0 +/- 7.4, 27.8 +/- 10.8, 25.1 +/- 7.9, 26.4 +/- 8.0 and 26.8 +/- 8.1 for trials A through F, respectively. In conclusion, the prior consumption of COF did not decrease the ergogenic effect of the subsequent ingestion of anhydrous CAF.
Article
We assessed the effect of ingestion of green tea (GT) extract along with a low-energy diet (LED) on resting energy expenditure (REE), substrate oxidation and body weight as GT has been shown to increase energy expenditure and fat oxidation in the short term in both animals and people. Forty-six overweight women (BMI 27 center dot 6 (sd 1 center dot 8) kg/m(2)) were fed in energy balance from day 1 to day 3, followed by a LED with GT (1125 mg tea catechins +225 mg caffeine/d) or placebo (PLAC) from day 4 to day 87. Caffeine intake was standardised to 300 mg/d. Energy expenditure was measured on days 4 and 32. Reductions in weight (4 center dot 19 (sd 2 center dot 0) kg PLAC, 4 center dot 21 (sd 2 center dot 7) kg GT), BMI, waist:hip ratio, fat mass and fat-free mass were not statistically different between treatments. REE as a function of fat-free mass and fat mass was significantly reduced over 32 d in the PLAC group (P < 0 center dot 05) but not in the GT group. Dietary restraint increased over time (P < 0 center dot 001) in both groups, whereas disinhibition and general hunger decreased (P < 0 center dot 05). The GT group became more hungry over time and less thirsty, and showed increased prospective food consumption compared with PLAC (P < 0 center dot 05). Taken together, the ingestion of GT along with a LED had no additional benefit for any measures of body weight or body composition. Although the decrease in REE as a function of fat-free mass and fat mass was not significant with GT treatment, whereas it was with PLAC treatment, no significant effect of treatment over time was seen, suggesting that a robust limitation of REE reduction during a LED was not achieved by GT.
Article
Although it is known that carbohydrate (CHO) feedings during exercise improve endurance performance, the effects of different feeding strategies are less clear. Studies using (stable) isotope methodology have shown that not all carbohydrates are oxidised at similar rates and hence they may not be equally effective. Glucose, sucrose, maltose, maltodextrins and amylopectin are oxidised at high rates. Fructose, galactose and amylose have been shown to be oxidised at 25 to 50% lower rates. Combinations of multiple transportable CHO may increase the total CHO absorption and total exogenous CHO oxidation. Increasing the CHO intake up to 1.0 to 1.5 g/min will increase the oxidation up to about 1.0 to 1.1 g/min. However, a further increase of the intake will not further increase the oxidation rates. Training status does not affect exogenous CHO oxidation. The effects of fasting and muscle glycogen depletion are less clear. The most remarkable conclusion is probably that exogenous CHO oxidation rates do not exceed 1.0 to 1.1 g/min. There is convincing evidence that this limitation is not at the muscular level but most likely located in the intestine or the liver. Intestinal perfusion studies seem to suggest that the capacity to absorb glucose is only slightly in excess of the observed entrance of glucose into the blood and the rate of absorption may thus be a factor contributing to the limitation. However, the liver may play an additional important role, in that it provides glucose to the bloodstream at a rate of about 1 g/min by balancing the glucose from the gut and from glycogenolysis/gluconeogenesis. It is possible that when large amounts of glucose are ingested absorption is a limiting factor, and the liver will retain some glucose and thus act as a second limiting factor to exogenous CHO oxidation.